Loyola University Chicago

Loyola eCommons
Dissertations

Theses and Dissertations

1992

Mechanisms Mediating Sympathoadrenal Activation During
Endotoxicosis in the Rat
Zhengzheng Zhou
Loyola University Chicago

Follow this and additional works at: https://ecommons.luc.edu/luc_diss
Part of the Physiology Commons

Recommended Citation
Zhou, Zhengzheng, "Mechanisms Mediating Sympathoadrenal Activation During Endotoxicosis in the Rat"
(1992). Dissertations. 3105.
https://ecommons.luc.edu/luc_diss/3105

This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons.
It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more
information, please contact ecommons@luc.edu.
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Copyright © 1992 Zhengzheng Zhou

LIBRARY· LOYOLA UNIVERS!T)'
MEDICAL CENTER

MECHANISMS MEDIATING SYMPATHOADRENAL ACTIVATION
DURING ENDOTOXICOSIS IN THE RAT

by
ZHENGZHENG ZHOU

A Dissertation Submitted to the Faculty of the Graduate School of Loyola University
of Chicago in Partial Fulfillment of the Requirements for the Degree of
Doctor of Philosophy

May

1992

Copyright by Zhengzheng Zhou, 1992
All rights reserved.

ii

ACKNOWLEDGEMENTS

I would like to express sincere gratitude to my advisor and mentor, Dr. Stephen B.
Jones, whose guidance, patience, encouragement and friendship are so precious to the
completion of this dissertation work. I will look back with pleasure the many hours we
spent discussing data and papers.
I would also like to thank my committee members, Ors. James P. Filkins, Robert
D. Wurster, Louis Van de Kar, and Robert F. Bond, for their selfless time and effort,
expert advice and valuable criticisms. The technique guidance offered by Dr. Wurster
and Dr. Van de Kar is greatly appreciated.
My appreciation is extended to Dr. Charles C. Webber not only for his help in
technical aspects but also his help in many other ways. I am also grateful to Maria
Weabber for her help in histological studies. I would particularly like to thank Dr.
Charles Brown of the University of Kentucky for teaching me the technique to record
renal sympathetic nerve activity in ~onscious animals.
Lastly, enormous thanks go to all the faculty members, staff and graduate students
in The Department of Physiology for their countless assistance and support throughout
the course of my training.

111

VITA

Zhengzheng Zhou, daughter of Qiaoxian Chang and Jingzhang Zhou, was born on
November 13, 1960 in Jilin, Jilin province, People's Republic of China (P.R.C.). She
attended elementary and secondary schools in Jilin, Jilin Province and graduated from
The Fourth High School in Xuzhou, Jiangsu Province in June, 1978.
In September, 1978, she enrolled in Shanghai Medical University in Shanghai,
P.R.C. and received her Bachelor Degree of Medicine in September, 1983. From
October, 1983 to July, 1985, she worked as a resident in Beijing Hospital and completed
her training in Internal Medicine.
In September, 1985, Zhengzheng entered the graduate program in Cardiovascular
Emergency Medicine at Beijing Union Medical University where she had advanced
training in both basic science and clinical medicine. She completed two years of the three
year program and received her pre-Master Degree of Science in July, 1987.
Zhengzheng began her graduate studies in the Department of Physiology at Loyola
University Stritch School of Medicine in September, 1987. Her dissertation work was
completed under the direction of Dr. Stephen B. Jones. Zhengzheng was the recipient of
a Schmitt Dissertation Fellowship in 1991.

IV

PUBLICATIONS

A. Refereed Journals:

1.

Zhou, Z.Z. and S.B. Jones. The vascular response to adrenergic stimulation in
pithed rats following endotoxin in the rat. Circ Shock 32(1):55-66, 1990.

2.

Zhou Z.Z., R.D. Wurster, M. Qi and S.B. Jones. Sympathoadrenal activation in
sinoaortic denervated rats following endotoxin. Am J Physiol. 260: R739-R746,
1991.

3.

Zhou Z.Z., R.D. Wurster and S.B. Jones. Arterial baroreceptors are not
dominant in mediating sympathoadrenal activation in conscious, endotoxic rats.
J Auton Nerv Syst, 1992. (in press).

4.

Zhou Z.Z. and S.B. Jones. Involvement of central versus peripheral mechanisms
in mediating the sympathoadrenal activation during endotoxicosis in rats. Am J
Physiol. (under revision).

5.

Zhou Z.Z., R.D. Wurster and S.B. Jones. Sympathoadrenal response to central
administration of endotoxin, IL-1, IL-6, and TNF in conscious rats. J Auton Nerv
Syst. (submited).

6.

Qi M., Z.Z. Zhou, R.D. Wurster and S.B. Jones. Mechanisms involved in the
rapid dissipation of the plasma epinephrine response to bacterial endotoxin in
conscious rats. Am J Physiol. 261:R1431-Rl437, 1991.

7.

Wang X., S.B. Jones, Z.Z. Zhou, C.D. Han and R.R. Fiscus. Calcitonin generelated peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma
and depleted in blood vessels during endotoxic shock in the rat. Circ Shock.
36:21-30, 1992.

V

B. Abstracts

1.

Wang X., S.B. Jones, Z.Z. Zhou, C.D. Han and R.R. Fiscus. Calcitonin generelated peptide (CGRP) levels in plasma are greatly elevated during endotoxic
shock in the rat. Circ Shock 24(4):242, 1988.

2.

Fiscus R.R., X. Wang, C.D. Han, Z.Z. Zhou, J. Gu and S.B. Jones.
Neuropeptide Y (NPY) levels are elevated in plasma and duodenum but depleted
in adrenal gland and vena cava during development of endotoxicosis in the rat.
The Pharmacologist 30(3):A72, 88 and The Physiologist 31:A72, 1988.

3.

Zhou Z.Z. and S.B. Jones. The vascular response to adrenergic stimulation in
pithed rats following endotoxin. Circ Shock 27(4):358, 1989.

4.

Zhou Z.Z., R.D. Wurster, M. Qi and S.B. Jones. Sympathetic activation
following endotoxin is not mediated by baroreflexes. Circ Shock 31(1):50, 1990.

5.

Qi M., Z.Z. Zhou and S.B. Jones. Rapid attenuation of epinephrine responses to
endotoxin in conscious rats. Circ Shock 31(1):57, 1990.

6.

Zhou Z.Z., R.D. Wurster and S.B. Jones. Sympathetic response to
intracerebroventricular (ICV) injection of endotoxin (ETX) and interleukin- I (IL1). FASEB J. 5(6): A1501, 1991.

7.

Jones S.B., R.D. Wurster, M. Qi and Z.Z. Zhou. Arterial baroreceptors are not
dominant in mediating sympathetic activation in conscious, endotoxic rats.
FASEB J. 5(6): A1501,1991.

8.

Fiscus R.R., X. Wang, Z.Z. Zhou and S.B. Jones. Endotoxin-induced elevations
of plasma calcitonin gene-related peptide (CGRP) levels develop tolerance after
multiple exposures to low-dose endotoxin. Circ Shock. 34(1): 51, 1991

9.

Wang X., S.B. Jones, M. Qi, Z.Z. Zhou and R.R. Fiscus. Histamine receptor
blockers cimitidine (H2-blocker) and diphenhydramine (HI-blocker) inhibit
endotoxin induced elevations in plasma levels of calcitonin gene-related peptide
(CGRP). Circ Shock. 34(1): 131, 1991.

Vl

TABLE OF CONTENTS

Page
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

VITA

ill

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv

PUBLICATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TABLE OF CONTENTS

V

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Vil

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

x

LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

x1

LIST OF TABLES

LIST OF ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xiv
CHAPTER I. INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1

CHAPTER II. REVIEW OF RELATED LITERATURE . . . . . . . . . . . . . . .
A.
SYMPATHOADRENAL ACTIVATION DURING THE
DEVELOPMENT OF SEPTIC/ENDOTOXIC SHOCK . . . . . . .
I.
Evidence for Sympathoadrenal Activation during Septic

6

Shock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Effects of Sympathoadrenal Activation during Septic
Shock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6

II.
B.

C.

REGULATION

OF

THE

SYMPATHETIC

6

8

NERVOUS

SYSTEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
I.
Spinal Cord Control . . . . . . . . . . . . . . . . . . . . . . . .
II.
Supraspinal Control . . . . . . . . . . . . . . . . . . . . . . . .
ill.
Central vs. Peripheral Involvement in Sympathoadrenal
Activation during Septic Shock . . . . . . . . . . . . . . . . . .

12

INVOLVEMENT OF ARTERIAL BARORECEPTORS IN
MEDIATING SYMPATHOADRENAL ACTIVATION DURING
SEPTIC/ENDOTOXIC SHOCK . . . . . . . . . . . . . . . . . . . . .
I.
Baroreceptor Reflex Control of the Circulation . . . . . . . .

14
14

vii

10
10
11

II.

D.

Afferent Neural Input from the Arterial Baroreceptors in
Mediating Sympathoadrenal Activation during Septic
Shock . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
III.
Resetting of Baroreceptor Reflexes during Septic Shock . . 16
POTENTIAL INVOLVEMENT OF CYTOKINES IN
MEDIATING SYMPATHOADRENAL ACTIVATION DURING

SEPTIC/ENDOTOXIC SHOCK . . . . . . . . . . . . . . . . . . . . .
I.
Biochemistry of Cytokines . . . . . . . . . . . . . . . . . . . .
1.
Interleukin-I (IL-1) . . . . . . . . . . . . . . . . . . . .
2.
Tumor necrosis factor (TNF) . . . . . . . . . . . . . .
3.
Interleukin-6 (IL-6) . . . . . . . . . . . . . . . . . . . .
II.
General Biological Effects of Cytokines . . . . . . . . . . . .
III.
Involvement of Cytokines in the Pathogenesis of
Septic/Endotoxic Shock . . . . . . . . . . . . . . . . . . . . . .
1.
Circulating cytokine levels in septic patients and
animal models . . . . . . . . . . . . . . . . . . . . . . .
2.
Duplication of septic syndromes by cytokine
administration . . . . . . . . . . . . . . . . . . . . . . . .
3.
Protective effects of cytokine antibodies . . . . . . . .
IV.
Centrally-Mediated Effects of Cytokines . . . . . . . . . . . .
1.
Fever . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2.
Neuro-endocine systems . . . . . . . . . . . . . . . . .
3.
Sympathetic nervous system . . . . . . . . . . . . . . .
4.
Others . . . . . . . . . . . . . . . . . . . . . . . . . . . .
V.
Passages of Cytokines to the Brain . . . . . . . . . . . . . . .
VI.
Evidence of the Hypothalamus as the Potential Action Site
of Cytokines in the Brain . . . . . . . . . . . . . . . . . . . . .
CHAPTER ill. GENERAL MATERIALS AND METHODS . . . . . . . . . . . .
A.
ANIMALS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
B.

CARDIOVASCULAR

INSTRUMENTATION

18
19
19
19
20
21
22
23
24
25
26
26
27
28
30
31
35
39
39

AND

G.

MEASUREMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SINOAORTIC BARORECEPTOR DENERVATION . . . . . . . .
SYMPATHETIC NERVE RECORDING . . . . . . . . . . . . . . . .
IMPLANTATION OF INTRACEREBROVENTRICULAR (ICV)
CANNULAE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IMPLANTATION OF CANNULAE TO PARA VENTRICULAR
NUCLEUS OF THE HYPOTHALAMUS (PVN) . . . . . . . . . . .
PITHING PROCEDURES . . . . . . . . . . . . . . . . . . . . . . . . .

H.

ADRENAL GLAND DENERVATION . . . . . . . . . . . . . . . . .

48

I.
J.
K.
L.

BLOOD SAMPLE COLLECTION . . . . . . . . . . . . . . . . . . . .
PLASMA CATECHOLAMINE ASSAY . . . . . . . . . . . . . . . .
AGENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DATA ANALYSIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

50
50
53
54

C.
D.
E.
F.

vm

39
41
42
45
46
47

CHAPTER IV. INVOLVMENT OF CENTRAL VS. PERIPHERAL
MECHANISMS IN MEDIATING SYMPATHOADRENAL
ACTIVATION IN ENDOTOXIC RATS . . . . . . . . . . . . . . . . . . . . .
A.
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
B.
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . .
C.
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . · ...
D.
DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

58
61
68

CHAPTER V. PLASMA CATECHOLAMINE RESPONSE IN SINOAORTIC
DENERVATED RATS FOLLOWING ENDOTOXIN . . . . . . . . . . . .
A.
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
B.
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . .
C.
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D.
DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

74
74
77
81
92

CHAPTER VI. RENAL SYMPATHETIC RESPONSE IN SINOAORTIC
DENERYATED RATS FOLLOWING ENDOTOXIN . . . . . . . . . . . .
A.
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
B.
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . .
C.
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
D.
DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

97
97
100
103
112

55
55

CHAPTER VII. SYMPATHOADRENAL RESPONSE TO CENTRAL
ADMINISTRATIONS OF ENDOTOXIN, INTERLEUKIN- I {3, TUMOR
NECROSIS FACTOR a AND INTERLEUKIN-6 IN CONSCIOUS
RATS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
A.
INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
B.
MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . 119
C.
RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
D.
DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
CHAPTER VIII. SUMMARY AND CONCLUSIONS................

145

CHAPTER IX. BIBLOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . .

154

1X

LIST OF TABLES

Table
1.

2.

3.

Effects of PVN injections of saline vehicle, IL-1 {3, TNF a and
IL-6 on mean blood pressure and heart rate. . . . . . . . . . . . . .

133

Effects of PVN injections of saline vehicle, IL-1 {3, TNF a and
IL-6 on renal sympathetic nerve activity spikes and slopes.

134

Effects of PVN injections of saline vehicle, IL-1 {3, TNF a and
IL-6 on plasma norepinephrine and epinephrine. . . . . . . . . . .

135

X

LIST OF FIGURES

Page

Figure
Chapter ill
3-1.

Oscilloscope display of amplified raw renal sympathetic nerve
activity from unrestrained, conscious rats. . . . . . . . . . . . . . . .

44

Chapter IV
4-1.

Mean blood pressure and heart rate responses in pithed rats with
adrenal sham operation or denervation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62

4-2.

Plasma norepinephrine and epinephrine responses in pithed rats
with adrenal sham operation or denervation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64

4-3.

Mean blood pressure and heart rate responses in conscious rats
with adrenal sham operation or denervation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65

4-4.

Plasma norepinephrine and epinephrine responses in conscious rats
with adrenal sham operation or denervation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

Chapter V

5-1.

5-2.

Changes of mean blood pressure and heart rate in response to
phenylephrine and nitroglycerine infusion in rats with acute sham
operation, acute sinoaortic denervation, chronic sham operation or
chronic sinoaortic denervation. . . . . . . . . . . . . . . . . . . . . . .

82

Mean blood pressure and heart rate responses in anesthetized rats
with acute SAD or sham operation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
xi

5-3.

Plasma norepinephrine and epinephrine concentrations in
anesthetized rats with acute SAD or sham operation following
intravenous endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . 85

5-4.

The mean blood pressure and heart rate responses in conscious rats
with chronic SAD or sham operation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86

5-5.

Plasma norepinephrine and epinephrine concentrations in conscious
rats with chronic SAD or sham operation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88

5-6.

Mean blood pressure and heart rate responses in conscious rats
with SAD or sham operation following hydralazine infusion.

5- 7.

89

Plasma norepinephrine and epinephrine concentrations in conscious
rats with chronic SAD or sham operation following hydralazine
infusion. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91

Chapter VI
6-1.

6-2.

6-3.

6-4.

6-5.

6-6.

Baroreflex test from a conscious sham-operated rat showing blood
pressure, heart rate, renal sympathetic nerve activity spike and
slope responses to intravenous phenylephrine and nitroglycerine.

104

Baroreflex test from a conscious SAD rat showing blood pressure,
heart rate, renal sympathetic nerve activity spike and slope
responses to intravenous phenylephrine and nitroglycerine. . . . .

105

Changes of mean blood pressure, heart rate, renal sympathetic
nerve activity spikes and slopes in response to intravenous
phenylephrine and nitroglycerine in conscious rats with SAD or
sham operation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

106

Mean blood pressure and heart rate responses in conscious rats
with SAD or sham operation following intravenous endotoxin. . .

107

Polygraph recording of blood pressure, renal sympathetic nerve
activity spike and slope responses in conscious rats with SAD or
sham operation following intravenous endotoxin. . . . . . . . . . .

109

Percent changes of renal sympathetic nerve activity spikes and
slopes in conscious rats with SAD or sham operation following
intravenous endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . .

110

xii

6-7.

Plasma norepinephrine and epinephrine concentrations in conscious
rats with SAD or sham operation following intravenous
endotoxin. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

111

Coronal brain section showing ventricular staining after dye
injection via an ICV cannula. . . . . . . . . . . . . . . . . . . . . . .

122

Coronal brain sections showing the tips of the PVN cannulae
terminating at the dorsal border of the nucleus. . . . . . . . . . . .

124

Hemodynamic, renal sympathetic nerve activity and plasma
catecholamine responses to ICV injection of endotoxin. . . . . . .

127

Hemodynamic, renal sympathetic nerve activity and plasma
catecholamine responses to ICV injection of low and high doses of
IL-1 {3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

128

Hemodynamic, renal sympathetic nerve activity and plasma
catecholamine responses to ICV injection of low and high doses of
TNF 0t. • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • •

130

Hemodynamic, renal sympathetic nerve activity and plasma
catecholamine responses to ICV injection of low and high doses of
IL-6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

131

Schematic representation of possible regulation of the
sympathoadrenal system during developing septic shock. . . . . .

153

Chapter VII
7-1.

7-2.

7-3.

7-4.

7-5.

7-6.

Chapter VITI
8-1.

xiii

LIST OF ABBREVIATIONS

NE

Norepinephrine

EPI

Epinephrine

MBP

Mean Blood Pressure

HR

Heart Rate

RSNA

Renal Sympathetic Nerve Activity

SAD

Sinoaortic Denervation

ADRDENERV

Adrenal Denervation

ICV

Intracerebroventricular

PVN

Paraventricular Nucleus of the Hypothalamus

IL-1

Interleukin- I

IL-6

Interleukin-6

TNF

Tumor Necrosis Factor

xiv

CHAPTER I

INTRODUCTION

Septicemia is a leading cause of morbidity and mortality among hospitalized
patients. There are approximately 400,000 cases each year in the United States, and the
incidence continues to increase (1). It has been estimated that gram-negative bacteremia
occurs in about 30 percent of patients with septicemia (32). Despite the use of potent
antibiotics and intensive supportive care, the mortality among patients with gram-negative
bacteremia remains high, varying from 20 to 60 percent (32,132,231). The common fatal
cause of overwhelming gram-negative bacterial infection is septic shock, a syndrome
characterized by inadequate tissue perfusion which ultimately leads to organ failure and
cellular death (3,97). Pathophysiological changes involve hemodynamic, metabolic,
neuroendocrine and immunologic alterations (3,252). Clinical manifestations include
chills, fever, hypotension, decreased vascular resistance, glucose dyshomeostasis,
lactacidemia, and the acute phase response.
Endotoxin, which is composed of lipopolysaccharide and associated proteins from
the gram-negative bacterial wall, has long been considered to be the principal causative
factor in the pathogenesis of gram-negative septic shock (103,167). Striking parallels
exist between the effects of endotoxin in experimental animals and those observed in
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2
patients with septic shock (104,122,168,171). Thus, endotoxin-treated animals have been
extensively used as an experimental septic model. Alternatively, recent experimental
findings suggest that endotoxin elicits most (if not all) of its pathophysiological effects
not directly but via stimulating different cell populations to release mediators. These
mediators, such as prostaglandins (230), leukotrienes (230), platelet activating factor (45)
and cytokines (78,79,171), have been linked to the pathogenesis of endotoxic shock.
Among many pathophysiological changes which occur during endotoxic shock is
markedly increased sympathoadrenal activity which has been viewed as a compensatory
response of the body to septic challenge (51). Evidence for this activation includes an
elevation of plasma catecholamines in septic patients and animal models (17,94, 113,115),
a depletion of tissue catecholamine content in the terminal state (187), and an enhanced
norepinephrine turnover in certain tissues during endotoxic shock (188). These findings
have been interpreted as an increased release of transmitters from sympathetic nerves and
the adrenal medulla. In addition, direct nerve recording has shown augmented
sympathetic nerve discharges in selective organs of endotoxic animals (92,185), although
some conflicting results have been reported (127,128). The sympathoadrenal activation
has been shown to have both detrimental and beneficial effects during the development
of septic shock (148). In the early stages, plasma catecholamines may support the
cardiovascular and metabolic adjustments to septic insult. Overwhelming and sustained
sympathetic activation, however, may contribute to the irreversibility of septic shock by
restricting nutritional organ blood flow. Even in light of these detrimental effects,
adrenergic agents have been widely used in patients with septic shock as a treatment to

3
support the cardiovascular system (33,50, 141). Although concerns were raised regarding
local ischemia of vital organs, particularly the kidney as a result of increased vascular
resistance (33), several recent studies report that norepinephrine therapy improves the
blood pressure and urine output (43,62, 197). The dual-sided effects of sympathoadrenal
stimulation in septic shock imply that a better understanding of the mechanisms of the
sympathoadrenal activation may allow prompt manipulations of the system and facilitate
the management of sepsis.
The mechanisms responsible for mediating the sympathoadrenal activation during

sepsis and septic shock are not clear and remain basically unexplored. The critical role
of centrally mediated mechanisms and neural dependence in the sympathetic activation
during developing endotoxic shock has been demonstrated in previous studies
(71,149,176,253). Recent studies using more sensitive catecholamine assay, however,
suggest the occurrence of peripheral modulations of catecholamine secretion from the
adrenal medulla during endotoxic shock (112,211). Evidence of non-neurogenic
stimulation of adrenal epinephrine secretion was provided by experiments showing that
ganglionic blockade could not prevent catecholamine release from the adrenal medulla

in septic animals (211). In vitro incubation of adrenal chromaffin cells with endotoxin or
other endotoxin-elaborated agents enhanced catecholamine secretion (177,225).
Another consideration emphasizes that the adrenergic discharge may be primarily
stimulated by endotoxin-induced systemic hypotension and associated baroreceptor reflex
deactivation (93,148). However, certain experimental findings challenge this concept and
suggest that the sympathoadrenal system can still be markedly activated by endotoxin or

4

gram-negative bacteria in the absence of significant hypotension (89, 115) and remain
activated after restoration of blood pressure (185).
It is now clear that cytokines, a family of protein molecules produced by
macrophages and other cells, are the key mediators in the pathogenesis of sepsis and
septic shock. Currently, growing evidence also suggests that cytokines such as
interleukin- I, interleukin-6 and tumor necrosis factor may mediate interactions between
the immune and neuroendocrine systems. On one hand, cytokines are produced mostly
by cells of the immune system and exert many actions during immune responses. On the
other hand, cytokines have a broad spectrum of actions including influences on
neuroendocrine functions. Among the cytokine actions, some involve the central nervous
system and may be initiated in the brain side of the blood brain barrier (107, 118, 194).
Brain tissues have receptors for and can respond directly to certain cytokines
(87,107,117,194,250). Furthermore, interleukin-I immunoreactive innervation of brain
areas was recently reported (34,136). In vivo production of interleukin-I, tumor necrosis
factor and interleukin-6 in the brain has been demonstrated in infectious and various
other pathological states (54,82,95,135). In vitro, brain cells have also been shown to
produce interleukin-I, tumor necrosis factor and interleukin-6 in response to endotoxin
or virus challenge (138,200). Thus, it is logical to propose that cytokines might be
plausible factors in mediating the sympathoadrenal activation with endotoxin via their
central actions.
Considering the clinical importance of gram-negative bacteremia and septic shock,
the involvement of the sympathoadrenal system in septic pathogenesis, the reappraisal of
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norepinephrine therapy in septic patients, and unknown mechanisms for the sympathetic
activation during sepsis, this dissertation was designed to explore some potential
mechanisms involved in mediating the sympathetic activation, using endotoxin-treated rats
as an experimental septic model. The specific aims of the following studies include: 1)
the examination of the overall contributions of central versus peripheral mechanisms to
the sympathoadrenal response during endotoxicosis, 2) the evaluation of the role of
afferent neural inputs from arterial baroreceptors in mediating the sympathoadrenal
activation in endotoxic animals, and 3) the assessment of the effects of centrallyadministered cytokines, interleukin-I, interleukin-6 and tumor necrosis factor, on central
sympathetic outflow.

CHAPTER II

REVIEW OF RELATED LITERATURE

A. SYMPATHOADRENAL ACTIVATION DURING DEVELOPING SEPTIC SHOCK

I. Evidence for Sympathoadrenal Activation during Septic Shock
Plasma catecholamines are shown to be elevated in human patients with septic shock
or serious infection in early stages (17,19,89). In most non-surviving patients, high
plasma norepinephrine and, to a lesser extent, epinephrine concentrations were sustained
but fell rapidly just before death (19). This fall is presumably due to either the depletion
of catecholamines from the adrenal medulla and sympathetic nerve endings or the overall
failure of the central nervous system. Plasma catecholamines have also been measured
in a variety of septic animal models (endotoxic, bacteremic, cecal-ligation and puncture
(CLP)) (112,113,115) and different species (dog, rabbit, cat, and rat) (94,99, 113,218).
Although the patterns and magnitude of the catecholamine response during
septic/endotoxic shock varied in these different models, the increases in plasma
concentrations were frequently demonstrated. For example, endotoxin administration in
rats resulted in a rapid (within 30 min) and dose-dependent elevation of plasma
catecholamines, in which norepinephrine elevation was sustained while epinephrine
6
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elevation declined with time (114). In contrast, the rat model of CLP had a prolonged
time course for the increment of plasma norepinephrine which developed hours after CLP
and remained elevated for 40 hours with only modest increase in epinephrine (126).
Depletion of tissue catecholamine content has been observed in the terminal state of
septic shock. Hanquet et al. (96) measured the catecholamine content of the adrenal
medulla removed from patients who had died of shock and reported a marked depletion
of catecholamine stores. In different animal species, endotoxic shock was also associated
with the depletion of adrenergic neurotransmitters in tissues such as heart, spleen and
adrenal medulla (98,187,254). Pohorecky et al.(195) indicated that such tissue depletion
was dose- and time-dependent following endotoxin. The depletion is speculated to be due
to a sustained release combined with decreased synthesis possibly caused by hypoxia and
acidosis.
Studies using radio-labeled norepinephrine and subsequent incorporation into the
existing transmitter pools showed that endotoxin induced a time-dependent decay in
specific activity of heart and spleen (188). This result indicates an increased
norepinephrine turnover and, hence, increased sympathetic activity during endotoxicosis.
Direct recording of sympathetic nerve discharge, in most cases, also revealed an
enhanced sympathetic nerve activity. In studies with anesthetized dogs and cats, Halinen
(92,93) demonstrated that endotoxin induced increased discharge of cardiac sympathetic
efferent nerves 15 min following intravenous administration. Cervical sympathetic nerve
activity was also found markedly elevated in anesthetized rats following endotoxin (159).
Using conscious, unstrained rats, Palsson et al. (185) showed that intravenous injection
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of either endotoxin or bacteria significantly enhanced renal sympathetic nerve activity.
In contrast to the above findings, Koyoma et al. (127,128) reported that preganglionic
splanchnic nerve activity and renal sympathetic nerve activity were decreased after
endotoxin injection in anesthetized cats and rabbits, respectively. It was concluded in
their studies that endotoxin treatment inhibited the central sympathetic outflow.
Collectively, a large body of literature can be found regarding the sympathoadrenal
activity during the development of septic shock and the demonstrations of its activation
in septic processes have been convincing and generally accepted. More thorough review
of this topic can be found elsewhere (186).

II. Effects of Sympathoadrenal Activation during Septic Shock
The sympathoadrenal system appears to be critically important, if not essential, in
maintaining life in the early stage of endotoxic shock in animals. Endotoxin treatment in
rats with adrenal demedullation or/and chemical sympathectomy are usually associated
with rapid onset of death and markedly increased mortality (131,156). Those animals
often have a very rapid and more profound fall in blood pressure and attenuated
tachycardia. This result suggests that both sympathetic and adrenal catecholamines
contribute importantly to the maintenance of arterial blood pressure and cardiac output
during endotoxicosis. Catecholamines are known to increase ventricular contractility,
which improves cardiac output, and mobilize liver glycogen to support increased tissue
metabolism during endotoxin shock (77, 125).
On the other hand, the detrimental effects of the sympathoadrenal activation during
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the development of endotoxic shock have also been suggested. Blunting of the excessive
sympathetic activation has been shown to protect against the shock pathogenesis (31,88).
For example, Lillehei and Maclean (140) pretreated dogs with alpha adrenergic
antagonist to block the vasoconstrictor effects of catecholamines released during
endotoxicosis. They found that this pretreatment significantly improved the survival rate
(84% lethality with endotoxin alone, 0% lethality with endotoxin and alpha blockade,

measured 72 hours after endotoxin) and alleivated the pathological changes. Filkins also
reported that alpha adrenergic blockade (phentolamine) protected rats against endotoxin
shock lethality and blunted the development of endotoxic hypoglycemia. In isolated
hepatocytes, alpha blockade protected against endotoxin-induced depression of hepatic
gluconeogenesis (76).
Exogenous catecholamines have been widely used in patients with septic shock to
support the failing cardiovascular system (33,50,139). Dopamine is particularly indicated
for treatment of patients with oliguria and decreased peripheral resistance. The use of
norepinephrine in septic patients is controversial due to the concerns regarding organ
ischemia as a consequence of diffusive vasoconstriction (33). However, interest in the
therapeutic use of norepinephrine has recently been reported (43,62, 197). Particularly in
septic patients with high cardiac output and low peripheral resistance, norepinephrine
treatment improved blood pressure and renal function without deleterious effects on
cardiac index, oxygen delivery and oxygen consumption (197).
A generally accepted view (148) is that in early phases of septic shock, the
sympathoadrenal activation may be beneficial by virtue of vasoconstriction in non-vital
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.ch favors the perfusion of more vital organs. Excessive sympathetic activation
organs wh1

may be

detrimental in the long run by restricting nutritional blood flow which ultimately
.

leads to severe metabolic and circulatory failure. Unfortunately, we still are unable to
determine with adequate precision when an increased sympathetic tone is no longer
beneficial during the developing septic shock.

B. REGULATION OF THE SYMPATHETIC NERVOUS SYSTEM

I. Spinal Cord Control
The traditional concept that the spinal cord serves solely as a relay station for
transmitting information from the medulla to postganglionic neurons innervating the
cardiovascular system is no longer tenable (14). Several observations indicate that
information processing in spinal neural circuits can be an important determinant of the
level of sympathetic control of the cardiovascular system. In animals with maximal
reduction of blood pressure and sympathetic nerve discharge by medullary transection at
the level of the obex, secondary section of cervical cord induced increases in sympathetic
nerve discharge (7). This implies that the final output from the central nervous system
to the circulation can be modulated by neurons in the spinal locus. Activation of somatic
and visceral afferent fibers produces reflex responses in sympathetic nerves which do not
require the integrity of bulbospinal pathways (207). Furthermore, blood pressure can
gradually return towards control levels and prominent cardiovascular reflexes can be
elicited in chronic spinal animals and man (14). Local intemeurons have been shown to
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exist in the intermediate gray matter of the spinal cord which innervate the sympathetic
preganglionic neurons at all levels of the sympathetic outflow (14). The presence oflocal
intemeurons implies that there are additional descending and intrinsic spinal pathways
that indirectly control the sympathetic outflow, but relatively little is known about these
pathways.

II. Supraspinal Control
Several interconnected central networks regulate the sympathetic outflow. The
incoming afferent fibers carrying visceral sensation from all the major organs of the body
including the cardiovascular system primarily terminate in the nucleus tractus solitarius
(NTS), the most important visceral sensory relay cell group in the brain stem. From
here, information is sent via intemeurons either to a number of key nuclei in the brain
stem which project directly to autonomic preganglionic neurons of the sympathetic and
the vagal systems or to the forebrain nuclei in the central autonomic network that are
capable of regulating both autonomic and neuroendocrine functions (143). Reciprocal
pathways between the NTS, the brain stem nuclei (ventrolateral medulla, the A5 cell
group, the parabrachial nucleus) and forebrain areas (the paraventricular hypothalamic
nucleus, the bed nucleus of the stria terminalis, and the central nucleus of the amygdala)
are the anatomical substrates for sympathetic regulation (143). Direct projections to the
intermediolateral cell column, where the sympathetic preganglionic neurons are located,
have been demonstrated to originate from seven areas of the brain (147,223): 1. the
rostral ventrolateral medulla, 2. the caudal raphe nuclei (raphe pallidus and raphe
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obscurus), 3. the A5 noradrenergic cell group, 4. the Kolliker-Fuse nucleus, 5. the
paraventricular hypothalamic nucleus, 6. the lateral hypothalamic areas, and 7. the
central gray matter.

m. Central vs. Peripheral Involvement in Sympathoadrenal Activation during Endotoxic
Shock
Lutherer et al. (149) showed that acute lesion of the cerebellar fastigial nuclei in
anesthetized dogs prevented the recovery and maintenance of blood pressure following
induction of hypotension either by hemorrhage or by administration of endotoxin. This
implies that the normal sympathetic response to endotoxin challenge requires intact
central regulatory mechanisms.
Intact spinal cord also seems critical to endotoxin-evoked sympathetic response.
Spinal transection at the C-7 level in dogs abolished the catecholamine release in
response to endotoxin, suggesting that endotoxin-elicited sympathoadrenal response was
presumably dependent on descending spinal pathways (71).
Additionally, endotoxin-induced elevation of plasma epinephrine was eliminated by
section of splanchnic nerves in the dog (176). Fine and associates (253) also
demonstrated that acute denervation of hemi-spleens protected against the norepinephrine
depletion whereas the intact spleen was depleted of norepinephrine, typical of the end
stage of endotoxic shock. This result suggests that increased catecholamine release during
septic shock depends on nerve activation.
Recent studies, using more sensitive catecholamine assay, show that peripheral
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modulation of catecholamine secretion from the adrenal medulla might be present during
endotoxin shock. In pithed rats with no centrally-mediated reflexes, endotoxin did not
elevate plasma norepinephrine but epinephrine was still augmented (112), although this
elevation was greatly attenuated compared to central nervous system (CNS) intact
animals. These results indicate that norepinephrine release depends on intact CNS while
epinephrine release may involve both CNS and peripheral (either neurogenic or nonneurogenic) mechanisms. Evidence of the non-neurogenic stimulation of adrenal
epinephrine secretion was provided by experiments in newborn rats showing that
ganglionic blockade could not prevent catecholamine release from the adrenal medulla
(211). Furthermore, in vitro incubation of adrenal chromaffin cells with endotoxin or
other endotoxin-elaborated agents enhanced catecholamine secretion (177,225).
Collectively, only a few studies have been conducted to evaluate central versus
peripheral involvements in mediating sympathetic activation during sepsis or septic shock.
The results were not consistent between studies, although it seems that the major
sympathoadrenal activation during sepsis is dependent on the intact CNS and peripheral
adrenal modulation may also be present. Further studies are needed to clarify whether
both central and peripheral mechanisms are involved in this event during septic states.
Thus, one of the present dissertation projects focuses on examining the central
dependence of the sympathoadrenal activation during septic shock as well as the
contribution of peripheral modulation to such activation.
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c.

INVOLVEMENT

OF

ARTERIAL

BARORECEPTORS

IN MEDIATING

sYMPATHOADRENAL ACTIVATION DURING SEPTIC SHOCK

I. Baroreceptor Reflex Control of the Circulation
Reflex regulation of the cardiovascular system is one of the important mechanisms
in maintaining the homeostasis of the internal environment. Two main types of receptors,

mechanoreceptors and chemoreceptors, exist in the cardiovascular system and are
involved in the major reflex control of the circulation. Arterial baroreceptors are the
mechanoreceptors located in the aortic arch and the carotid sinuses, which monitor
arterial blood pressure. Afferent sensory fibers from baroreceptors project to the nucleus
tractus solitarius in the medulla. From there, information is sent to the brain stem nuclei
which may project directly to the ambiguous nucleus of vagal nerve and the sympathetic
preganglionic neurons in the intermediolateral column of the spinal cord (220). Studies
have demonstrated that baroreceptor reflexes can be modified by peripheral as well as
central mechanisms (47).

II. Afferent Neural Input from the Arterial Baroreceptors in Mediating Sympathoadrenal
Activation during Developing Septic Shock
Since hypotension typically occurs along with increases in heart rate, sympathetic
nerve discharge and plasma catecholamines during endotoxic shock (93,113,185), it is
suggested that endotoxin induced-hypotension may be the primary cause of the
sympathoadrenal activation by unloading baroreceptors and associated deactivation of
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baroreflexes. In anesthetized dogs and cats, Halinen et al. (92,93) demonstrated that
endotoxin administration induced a rapid drop of blood pressure which was associated
with cessation of the aortic arch baroreceptor afferent impulses and increased cardiac
sympathetic efferent discharges during their 15 min protocol. The author concluded that
the sympathetic pathways were primarily activated through cardiovascular receptor
reflexes to maintain blood pressure. Baroreceptor reflex participation in mediating
sympathetic activation during endotoxic shock has also been suggested by several other
investigators (159,185).
However, certain experimental findings in the literature challenge the concept that
baroreceptor reflexes are the dominant factor in mediating the sympathoadrenal activation
following endotoxicosis. In rats treated with E. coli bacteria, plasma catecholamines were
markedly increased while blood pressure was not significantly altered (115). In
experiments involving bolus administration of endotoxin, plasma catecholamines were
also markedly enhanced well before hypotension occurred (114). Complete blockade of
early endotoxin-induced hypotension with platelet activating factor antagonist did not
prevent catecholamine elevations following endotoxin (196). Direct nerve recording in
endotoxin and E.coli bacteria treated-animals indicated that sympathetic nerve discharge
markedly increased with transient decrease in mean blood pressure and remained elevated
when blood pressure returned to the control levels (185). Mills (159) studied the
sympathetic response to endotoxicosis in pre-weanling rats before maturation of
baroreflex and adult rats with matured baroreflex. He reported that sympathetic nerve
discharge was augmented prior to the onset of hypotension in both groups of rats and
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additional increases in nerve activity occurred following the fall in blood pressure in
adults rats but not in pre-weanling rats. The increased activity in both groups persisted
after blood pressure was restored to basal levels with volume infusion. The author
concluded that although there was baroreflex participation in the sympathetic activation
during the hypotensive phase following endotoxicosis, the initiation and continuous
activation were mediated by non-baroreflexogenic mechanisms.
Sympathetic activation independent of hypotension was also observed in septic
patients. Groves et al. (89) reported significantly elevated plasma catecholamines in
patients with serious postoperative infection. Although some patients in their studies had
low blood pressures, most were normotensive and none were hypovolemic when plasma
catecholamines were elevated. They suggest that factors other than the baroreceptor
reflexes are important causes of increased plasma catecholamines in septic patients.
Failure to demonstrate a direct relationship between the degree of hypotension and the
sympathetic activation has been reported elsewhere (96).

ill. Resetting of Baroreceptor Reflexes during Endotoxin Shock
The function of the carotid sinus baroreceptors during endotoxemia was investigated
by Trank and Visscher (238) in pentobarbital anesthetized dogs with cut sinus nerves.
Endotoxin was shown to produce a left shift of baroreceptor discharge frequency versus
intrasinus pressure curve. This resetting resulted in post-endotoxin baroreceptor discharge
frequencies always being higher for a given pressure stimulus compared to control levels.
The authors speculated that the effect of endotoxin on the carotid sinus baroreceptor
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activity was not a direct receptor stimulation but an indirect effect produced through a
chemical mediator released during endotoxicosis. This mediator may sensitize the
receptors or modify the physical properties of the muscular or elastic components of the
carotid sinus wall, but the nature of the mediator was not known.
Recent studies have shown that baroreceptor reflexes can be modulated by certain
circulating factors. Prostanoids, substance P, atrial natriuretic factor, and vasopressin
have all been demonstrated to augment the baroreflex control of the circulation
(35,44,74,249). In other words, at a given carotid sinus pressure those mediators either
decrease the afferent nerve activity of baroreceptors (peripheral resetting) or increase the
central efferent sympathetic outflow (central resetting). In contrast, PGI2 , opiates,
endothelial factor, and neurotensin have been linked to the suppression of baroreceptor
reflexes (48,49,228,256). This suppression was also achieved either by peripheral
baroreceptor resetting (i.e. increased baroreceptor afferent activity) or by central resetting
of the coupling between the baroreceptor afferent and nerve efferent activities (i.e.
decreased central efferent sympathetic activity). These findings may have implications
in the sympathetic response during septic shock, such that the augmentation of

baroreceptor reflexes may be involved in reducing sympathetic activity whereas
suppression of baroreceptor reflex may contribute to enhanced sympathetic outflow.
As can be summarized from the evidence reviewed in the above two sections (II and
III), hypotension does not necessarily initiate or maintain the increased sympathoadrenal
activity which occurs with septic insult despite baroreflex participation for such activation
during hypotensive state. Modulation of baroreflexes by certain mediators may also
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influence the sympathetic activation during sepsis, but the nature of such mediator is
unknown. Regardless of the causes of baroreflex deactivation, the role of baroreceptors
in mediating sympathetic activation during sepsis/endotoxicosis has never been directly
evaluated. This will be another focus of the present dissertation studies.

D.

POTENTIAL

INVOLVEMENT

OF

CYTOKINES

IN

MEDIATING

SYMPATHOADRENAL ACTIVATION DURING SEPTIC SHOCK

Cytokines are a family of closely related proteins produced primarily by
monocytes/macrophages and lymphocytes in response to microbial infection, injury,
physiological stress, or antigenic challenge (9). Although not released by a specialized
gland, cytokines, like hormones, can act in autocrine, paracrine, and/or endocrine
fashions to stimulate their producing cells, local vicinity tissues, or distant sites (65,198).
Cytokines have a wide range of biological effects on target cells and are responsible for
mediating a variety of processes in host defense, inflammation, and responses to injury.
Extensive studies have demonstrated that cytokines are the principal mediators for the
pathogenesis of endotoxin/septic shock (37,79,174). Particularly, interleukin-1 (IL-1),
tumor necrosis factor (TNF), and interleukin-6 (IL-6) may be grouped together on the
basis of related patterns of production and several overlapping activities to mediate
common effects in the development of septic shock (198). Growing evidence suggests
that there are interactions between immune and neuroendocrine systems with those
cytokines as likely mediators.
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1. Biochemistry of Cytokines

1. Interleukin- I (IL-1)

Although activated macrophages are the major source of IL-1, this cytokine is also
produced by a variety of other cells including fibroblasts, endothelial cells, T and B
lymphocytes, as well as brain astrocytes and microglial cells etc. (162). IL-1 is initially
synthesized as a 33,000 dalton precursor, which is subsequently processed during or after
secretion to molecular weight forms in the range of 13,000-17,000 daltons (86). Two
distinct genes, IL-1 a and IL-1 {3, have been identified and localized to the long arm of
chromosome 2. The mature forms of IL-1 a and IL-1 {3 exhibit limited amino acid
homology (22-26%) and different isoelectric points (pI5 for IL-1 a and pI7 for IL-1 {3)
(2). In most human tissues IL-1 {3 mRNA predominates over IL-1 a (9). Both molecules
interact with the same membrane-associated receptors and their biological activities
appear to be identical (68,198). The human and murine IL-1 {3 or a share approximately
60-70% homology (198).

2. Tumor Necrosis Factor (TNF)
TNF a, also known as cachectin, is a single polypeptide chain of 156-158 amino
acid residues produced primarily by activated monocytes/macrophages in response to a
variety of agents including endotoxin, Bacille Calmette Guerin (BCG), and phorbol esters
(191,233). Natural killer cells, T lymphocytes, astrocytes and some macrophages or
tumor cell lines can also produce TNF (52,138,192,200,219). TNF is produced as a
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prohormone which undergoes extensive cleavage to generate the mature protein. Studies
have suggested that human TNF ex exists as a dimer or trimer which dissociates into a
monomer with molecular weight of 17,000 daltons under denaturing condition (4). TNF
ex is pH and temperature sensitive. The gene for TNF ex has been found on chromosome

6 in man (217), which is linked to the gene encoding lymphotoxin that is also called TNF
{3. TNF ex and TNF {3 have a 28 % sequence homology as well as they bind to the same

receptor and evoke similar biological responses (173). TNF is a highly conserved
protein, as illustrated by approximately 80% homology between mouse, rabbit and human
TNF (109,154).

3. Interleukin-6 (IL-6)
IL-6 is a glycoprotein with a molecular weight of 23,000-30,000 daltons
(heterogeneity in size being a function of different glycosylation) (162). The peptide is
stable at 56 °C but is rapidly inactivated at 100 °C (198). IL-6 can be produced by
diverse cell types including fibroblasts, monocytes/macrophages, endothelial cells, T and
B cells, mesangial cells and astrocytes upon appropriate stimulations (162). Those stimuli
include endotoxin, IL-1, TNF alpha, platelet-derived growth factor and virus infection.
The human IL-6 gene is located on chromosome 7 (210). About 60 % homology between
human and mouse has been shown at the DNA level and 42% at the protein level (123).

II. General Biological Effects of Cytokines
IL-1, TNF, and IL-6 are the most typical examples of multifunctional cytokines.
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Their functions are widely overlapping, but each shows its own characteristic properties.
IL-1 was originally discovered as an endogenous pyrogen which induced fever
(198). IL-1 has a broad spectrum of target cells that share a common involvement in
immune or inflammatory responses. For example, IL-1 aids in the development of
specific immune responses by regulating the activation of T and B cells and by
stimulating the release of growth and differentiation factors that act on T and B cells
(5,63,174). IL-1 has proinflammatory effects on a variety of cells including fibroblasts,
synoviale cells, chondrocytes, endothelial cells, hepatocytes, and osteoclasts (63,162).
IL-1 also increases the hepatic acute phase protein synthesis and mediates many other
metabolic alterations (64, 78). A key feature of IL-1 action is to stimulate the arachidonic
acid

metabolism which may be involved in many responses in different organs or

systems such as cardiovascular, pulmonary, and neuroendocrine systems (63,140,198).
TNF was first identified as an endotoxin-induced factor causing hemorrhagic
necrosis in certain tumors in vivo (42). It is now evident that both TNF a and fJ possess
cytolytic and cytostatic properties for certain solid tumors in vivo and specific tumor lines

in vitro (9). TNF a appears to play a major role in trapping neutrophils in a localized
inflammatory area by increasing the expression of adhesion molecules on the surface of
both endothelial cells and neutrophils (36,124). TNF a could further stimulate neutrophil
phagocytosis and superoxide anion production as well as be involved in driving the
anticoagulant status of the endothelium to a procoagulant state (124). TNF a can also
induce some cells such as endothelial cells and fibroblasts to secrete a number of
important immune mediators (198). These mediators, including IL-1, platelet-activating
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factor, prostaglandins, interferons, colony-stimulating factor (CSF) and collagenase, may
actively participate in local and systemic immune responses. TNF

0t

has been

demonstrated to induce the differentiation and proliferation of B lymphocytes (110). TNF
a also has endogenous properties to cause fever (66) and is involved in acute phase

response (24). Suppression of lipoprotein lipase production may be one of the
mechanisms for cachexia associated with TNF (163).
IL-6 was initially described as T cell derived-lymphokine that induced antibody
production in B cells (123). IL-6 can markedly influence the growth and differentiation
of T and B lymphocytes, especially in the presence of other stimuli such as IL-1 (5). IL-6
can also stimulate the growth of hematopoietic colonies composed of granulocytes and
macrophage and modify the effects of other hematopoietic factors (123). Nerve-growth
factor-like activity of IL-6 has been suggested. IL-6 can act as a pyrogen (100) and is
involved in mediating the acute phase responses by liver cells (83).
A cytokine network exists, as indicated by the induction of these cytokines (5). For
example, TNF induces IL-1 expression and vice versa. IL-1 and TNF both induce IL-6.
Unlike IL-1 and TNF, IL-6 does not induce IL-1 or TNF. IL-6 suppresses endotoxin- or
TNF-induced IL-1 production as well as endotoxin-induced TNF production. Moreover,
IL-1, IL-6 and TNF are each capable of inducing their own production. Thus, this
network implies complex functional links between those cytokines.

III. Involvement of Cytokines in the Pathogenesis of Septic/Endotoxin Shock
The involvement of IL-1, TNF and IL-6 as key mediators in the pathogenesis of
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septic/endotoxic shock are mainly demonstrated by three separate lines of evidence. First,
a marked elevation of production and secretion of each of the cytokines have been
demonstrated during the development of septic/endotoxin shock. Second, administration
of exogenous cytokines can duplicate most of the manifestations and pathophysiological
changes associated with septic/endotoxic shock. Third, treatment of the septic animals
with specific antibodies against those cytokines shows protective effects and decreases
lethality.

1. Circulating Cytokines Levels in Septic Patients and Animal Models
Several investigators have demonstrated that in septic patients, there are elevations
of plasma TNF levels, either alone or along with increased IL-1 or IL-6
(41,57,60,178,245). High level of TNF or IL-6 has been associated with severity and
high mortality in some studies (178,245). Michie et al. (158) reported that endotoxin
administration (4 ng/kg) to healthy human volunteers induced a 7 fold single peak
elevation of plasma TNF levels within 90 -180 min while IL-1 level did not change.
However, detectable elevations of IL-1 at 120 min and IL-6 at 2 to 4 hr following
endotoxin in human volunteers have been demonstrated in other studies (80,101).
Increases in circulating TNF, IL-1, and IL-6 have been substantiated in septic
models

with

endotoxin

or

bacterial

injections

in

different

animal

species

(73,81,121,155,244). Mathison et al. (155) reported that elevation of plasma TNF was
detected within 30 min and peaked between 45 to 120 min after endotoxin challenge in
rabbits. In studies with baboons, Fong et al. (81) demonstrated that circulating TNF was
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increased with peak elevation at 1.5 hr after E. coli injection. IL-1 was detectable by 2
hr and peaked 3 hr after bacterial infusion. IL-6 was detectable within 3 hr and continued
to rise throughout 8 hrs of the protocol.

2. Duplication of Septic Syndromes by Cytokine Administration
Extensive studies have shown that TNF administration in different animal models
precipitates a syndrome strikingly similar to that of human septic shock (18,53,234,236).
Tracey et al. (234) reported that recombinant human TNF infusion induced dose-related
endotoxin-like syndrome, tissue injury, and death. Endotoxic shock-like syndrome was
also observed in TNF-treated rats, including hypotension, tachycardia, hyperglycemia,
lactacidemia, hemoconcentration. Pathological analysis revealed organ-specific changes
indistinguishable from those seen during human septic shock such as adrenal necrosis,
pulmonary inflammation and hemorrhage. Cardiovascular collapse along with tissue
necrosis and elevation of stress hormones was also observed in canine models after TNF
infusion (236). The modulation effects of TNF on endotoxin-induced hemodynamic,
metabolic and endocrine responses have been demonstrated (53).
Relatively few studies have examined the pathophysiological alterations associated
with IL-1 administration. Okusawa et al. (179) reported that intravenous treatment of ILI

/3 (5 mg/kg) to rabbits induced hypotension, decreased vascular resistance and

decreased central venous pressure. In studies with mice, Beutler et al. (40) demonstrated
that IL-1 ex and (3 induced dose-dependent lethality and pathological changes similar to
septic shock. Using nontoxic doses of IL-1 (3 and TNF in combination in rabbits, a
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profound shock-like state was induced with evidence of pulmonary edema and
hemorrhage (179). It is suggested that the combination of IL-1 and TNF together is much
more potent than either agent alone.

3. Protective Effects of Cytokine Antibodies
Using polyclonal rabbit antiserum and the derived IgG against TNF to passively
immunize mice, Beutler et al. (25) reported that endotoxin induced lethal effects were
significantly attenuated in a dose-dependent manner. The protective effects were most
effective when antiserum was given prior to endotoxin injection. Tracy et al. (235)
reported that pretreatment of baboons with monoclonal anti-TNF antibody fragments
(Fab2) 2 hr before LD 100 of E. coli bacteria infusion provided complete protection
against shock, vital organ dysfunction, and persistent stress hormone release. Anti-TNF
antibodies also attenuated the E. coli bacteria-induced elevation of TNF, IL-1

/3 and IL-6

(81), suggesting that TNF may be essential for the initiation and amplification of IL-1
and IL-6 release during septic shock.
Wallach et al. (246) demonstrated that treatment with IL-1 (0.4 µg, ip) 12 hr before
endotoxin injection (100 µg, iv) to BCG-primed mice prevented the lethal effects of
endotoxin, suggesting that IL-1 was an important mediator in endotoxin lethal effects.
In recent studies by Starnes et al. (221) the effects of in vivo anti-mouse IL-6

antibody treatment were evaluated in a mouse model of septic shock.

Anti-IL-6

antibodies significantly attenuated the lethality caused by E. coli (ip) or murine
recombinant TNF a, suggesting that IL-6 is an important mediator in lethal E. coli
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infection. Anti-IL-6 also led to an increase in E. coli induced elevation of serum TNF
levels, implicating that IL-6 was a negative modulator of TNF in vivo.
Clearly, extensive studies have demonstrated that TNF, IL-1 and IL-6 are the
principle mediators in the pathogenesis of sepsis and septic shock. More exhaustive
review of this topic can be found in a recent monograph (79).

IV. Centrally-Mediated Effects of Cytokines

1. Fever
Fever is well known to be a centrally-regulated response. The temperature regulation
center is primarily located in the anterior hypothalamus (10). When endotoxin, the
exogenous pyrogen was administered intravenously (i. v .) to rabbits, it caused monophasic
fever at small doses but biphasic fever at larger doses (164). It is now recognized that
the exogenous pyrogens exert their pyrogenic effects by releasing several endogenous
pyrogens such as TNF a, IL-1, and IL-6. These systemically released cytokines are
presumably transported to the brain by the blood and initiate fever by increasing
prostaglandin PGE2 synthesis in the hypothalamus. It is not known how the cytokine
signals in the circulation get into the hypothalamus (26,222).
Intravenous injection of human recombinant IL-1 into rabbits resulted in a
monophasic fever which peaked approximately 50 min after injection (66). This fever
induction was more rapid than endotoxin-induced fever which peaked approximately 90
min post administration. TNF a is also pyrogenic and has dose-dependent fever-inducing
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properties. Small i. v. dose of TNF induced a brisk, monophasic fever which peaked
coincidentally with IL-I induced fever (66). High doses of TNF a resulted in a biphasic
fever profile. The initial peak, which was corespondent to the monophasic peak observed
with small dose of TNF, was followed by a second peak at 3.5 hr post injection.
Pretreatment with a cyclooxygenase inhibitor could block IL-1 induced fever as well as
the initial rise in temperature evoked by TNF. The second peak has been demonstrated
to be mediated by TNF-induced IL-1 release (66,243). Intravenous injection of IL-6 to
rabbits also produced fever response which was monophasic with peak elevation around
60 min (100).

2. Neuro-Endocrine System
Extensive studies have been conducted to investigate the cytokine effects on the
neuro-endocrine systems, particularly the hypothalamus-pituitary-adrenal axis.
IL-1 has been reported to increase serum levels of adrenocorticotrophic hormone
(ACTH) and corticosterone in different species (22,182). Such elevations are primarily
mediated through central mechanisms. Intracerebroventricular (ICV) administration of
IL- I-stimulated secretion of ACTH and corticosterone, whereas the same dose was not
effective when injected peripherally (119,182). It has been shown that IL-1 stimulates
ACTH and subsequent corticosterone secretion by triggering release of corticotropinreleasing factor (CRF) from the hypothalamus, as measured from both systemic (22) and
hypothalamic-pituitary portal circulations (206). Pretreatment with CRF antibodies
abolished the IL- I-induced increase in ACTH (206). Complete neural dissociation of the
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medial basal hypothalamus prevented the adrenocortical activation produced by IL-1
(182). Additional effects of IL-1 at the level of the pituitary and the adrenal gland has
also been proposed ( 16).
Similarly, TNF as well as IL-6 have also been demonstrated to stimulate the
hypothalamic-pituitary-adrenal axis (53,59,72,170,213,236,247). In vitro incubation of
the pituitary with IL-6 induced ACTH secretion (150). Intravenous administration ofIL-6
into rats increased the plasma level of ACTH 30 min after the injection (170).
Pretreatment with anti-CRF completely abolished the IL-6 induced increase of ACTH
(170), suggesting that IL-6 stimulated the secretion of ACTH through CRF.
Recent evidence indicates that IL-1 and TNF modulate the secretion of various other
hypothalamic-pituitary peptides, including prolactin, growth hormone, thyrotropinreleasing hormone, and luteinizing hormone-releasing hormone (26,199).

3. Sympathetic Nervous System
Cytokine-induced activation of the sympathetic nervous system has been reported
by several authors. In 1987, Tracey et al. (236) investigated the stress hormone responses
to recombinant human TNF in anesthetized dogs. Intra-arterial infusion of sublethal dose
of TNF (10 µg/kg) induced no significant changes in plasma catecholamines. Lethal dose
of TNF (100 µg/kg),

however,

precipitated significant increases of plasma

catecholamines. Within 15 min after TNF infusion, plasma epinephrine and
norepinephrine increased from a pre-injection value of 58 and 282 pg/ml to 1148 and
1400 pg/ml, respectively. By 3 hrs, plasma epinephrine and norepinephrine were elevated
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to 1623 and 1982 pg/ml, respectively. Since these elevations occurred prior to the onset
of diminished mean blood pressure or cardiac output, the authors proposed that
circulating TNF may stimulate the sympathetic response. Sharp et al. (213) showed that
ICV injection of TNF was more effective than intravenous (iv) injection, which may
suggest a central site of action for TNF.
In 1988 Bagby et al.(11) demonstrated that non-lethal dose of TNF (150 µg/kg, iv)
induced about 2-3 fold increase in plasma epinephrine and norepinephrine in conscious
rats, which was not associated with hypotension. Similar findings were also observed by
Darling et al. (59), except that the increment of epinephrine did not reach statistical
significance. In recent studies with conscious rats, Ciancio et al. (53) reported that
significant elevation in plasma catecholamine were induced within 90 min after high dose
of TNF injection (1 mg/kg), with peak elevation of approximately 20 fold.
In anesthetized dogs Evans et al. (72) reported that 6-hr infusion of sublethal dose
of TNF increased stress hormone levels including plasma catecholamines, which were
associated with hemodynamic and metabolic changes. Pretreatment with cyclooxygenase
inhibitors abolished most of the hemodynamic changes and attenuated elevation of plasma
catecholamines. In contrast to the plasma catecholamine response to TNF, Holt et al.
(106) reported that ICV injection of TNF ex resulted in decreased sympathetic firing rate
to interscapular adipose tissue, whereas lymphotoxin (TNF {3) increased the sympathetic
nerve activity to that tissue. The authors proposed that both cytokines acted directly in
the CNS to modulate sympathetic outflow, possibly via separate receptor systems.
Recombinant IL-1 ex and IL-1 {3 have also been evaluated for their ability to
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stimulate catecholamine secretion in the rat (202). Intravenous injection of either IL-1 a
or IL-1 {3 (1-1000 ng) caused dose-related but modest increases in plasma catecholamines
at 15 min post injection. Similarly, ICY administration of same doses of IL-1 induced
2-3 fold elevation of plasma catecholamines. In both cases no alteration in blood pressure
occurred, suggesting that this elevation does not result from a cardiovascular reflex.
A recent study assessed norepinephrine turnover in various organs of rats after
intraperitoneal injection of recombinant human IL-1 {3 (6). IL-1 administration increased
norepinephrine turnover in the spleen, lung and hypothalamus. Modest elevation of
plasma catecholamine levels was also observed 30 min and 1 hr following intraperitoneal
IL-1 injection (21).
Saigusa (204) studied the regional sympathetic response to IL-1 {3 and TNF a using
anesthetized rabbits. He found that each of the cytokines typically induced a decrease in
ear temperature, indicative of cutaneous sympathetic activation, and simultaneous
inhibition of renal sympathetic nerve activity at the initial phase (30 min) which returned
to control levels around 60 min post treatment.

4. Others
In addition to the above-mentioned central effects of cytokines, IL-1 and TNF have
also been shown to induce many other centrally-mediated host defense responses to
infectious

pathogens.

Among

those

are

acute-phase

glycoproteinemia

(214),

hyperinsulinemia (55), increased counts of white blood cells, enhanced slow-wave sleep
(30) and suppression of food intake (194).
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v.

Passages of Cytokines To the Brain
A prerequisite for a direct CNS effects of systemic endotoxin or cytokines is that

the specific molecule contacts CNS elements. Controversial results have been reported
in the literature regarding the possibility of systemic endotoxin and cytokines entering the
CNS and interacting with the brain parenchyma.
Prior to the understanding of cytokines, endotoxin was believed to be the causative
factor for the pathogenesis of gram-negative septic shock. At that time, some evidence
suggested direct actions of endotoxin on the CNS which might be responsible for some
of its effects. Experiments were then onducted attempting to establish the basis of direct
contact of endotoxin with CNS components. Bennett et al. (20) presented evidence that
endotoxin was found in cerebrospinal fluid (CSF) of dogs within 15-30 min after
intravenous injection of Shigella endotoxin, using the pyrogenic effects in rabbits as an
assay. In contrast, most other studies reported negative results in general. When
radioactive-labelled endotoxin was given systemically, no endotoxin was found in the
brain parenchyma although radioactivity was detected throughout peripheral organs ( 109).
In another experiment involving intravenous endotoxin administration, no endotoxin was
detected in the CSF during the period when plasma endotoxin was at its highest
concentration (240). Although in a few cases of this experiment, a low level of endotoxin
was found in the CSF, it was usually correlated with high red blood cell count in the
CSF, and it was considered to be due to contamination from cerebral bleeding during the
CSF sampling. From these studies, the generally accepted view is that endotoxin cannot
cross the blood brain barrier.
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It is now recognized that host-released factors, primarily cytokines, are responsible

for most of endotoxin effects, including those involved in the CNS. However, whether
cytokines have direct physical contact with the brain tissues is not clear. Experiments in
the past several years have focused on three major aspects: 1) whether cytokines can
cross the blood brain barrier, 2) whether circulating cytokines enter the brain at the
circumventricular organs where the blood brain barrier is absent, and 3) whether
cytokines are produced locally in the brain and, thereby, exert their actions.
In 1987 Dinarello et al. (67) reported that intravenous injection of

125

I labelled

endogenous pyrogen (EP), prepared from monocytes, did not induce any radioactive
detection in the anterior hypothalamus. In 1987 the same group (54) reported that when
endotoxin or IL-1 was given intravenously, CSF IL-1 concentration did not increase at
any stages of the sustained fever, suggesting that IL-1 did not cross the blood brain
barrier. In contrast, when pyrogenic doses of endotoxin or IL-1 (3 was administered ICY,
elevation of IL-1 in the CSF was detected, indicating the ability of brain tissues to
produce IL-1 in vivo. Bank et al. (12) reported bidirectional transports of IL-1 a across
the blood brain barrier. In their studies

125

I-radiolabled IL-1 a, which retains full

biological activity, was injected intravenously into mice along with 99J'e-radiolabled
albumin. When the brain/serum radioactivity ratio was counted at different times post
injection, the ratio for

125

I increased significantly over time whereas the ratio for 99J'e

stayed constant, suggesting that there was a blood to brain transport of IL-1 but not
albumin. Many regions of the brain contained IL-1 radioactivity. The brain to blood
transport of IL-1 was also demonstrated in the same studies.
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In another line of investigation, the possible role of organum vasculosum laminae
terminalis (OVLT) in connection with the pathogenesis of fever and activation of
hypothalamic-pituitary-adrenal axis was extensively studied. OVLT is one of the seven
or eight so called "circumventricular organs"as it is adjacent to the cerebral ventricles.
The OVLT is highly vascularized and lacks a blood brain barrier (111). Some big
molecules such as horseradish peroxidase (HRP) (45,00 dalton) can not cross the blood
brain barrier but can reach interstitial space of the OVLT (222). The ependyma of the
OVLT faces toward the third ventricle and the parenchyma of the OVLT is comprised
of neuronal perikarya, glial and neuronal processes. The OVLT is close to the
hypothalamus and has direct projections to the hypothalamus which is known to be an
important area in autonomic, endocrine and fever regulations (111).
In studies with guinea pigs, Blatteis reported that an extensive lesion of the

anteroventral third ventricular wall including OVLT resulted in suppression of the febrile
response evoked by systemically administered endotoxin, IL-1 and TNF (27-29). Direct
injection of endogenous pyrogen into the preoptic region of the hypothalamus in the
lesioned rats, however, induced fever similar to that seen in sham rats (27). They
proposed that the OVLT may be the passage site of systemic endogenous pyrogens to the
preoptic region of the hypothalamus which directly responds to pyrogens to induce fever.
Thus, lesions of the OVLT subsequently prevent the entry of pyrogens into the brain.
In contrast, Stitt et al. (222) reported different findings. Small perhaps incomplete

lesion of the OVLT region in rabbits greatly augmented the febrile response to
endogenous pyrogen with maximum responses 3-6 days post lesions which gradually
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diminished over 3-4 weeks. They suggested that this enhanced response may be due to
increased phagocytosis in the remaining OVLT cells since zymosan, a phagocytotic
stimulating agent, produced similar enhancement of the febrile response. Similarly,
Katsuura et al. (116) demonstrated that OVLT lesion enhanced the intravenous IL-1 {3induced ACTH response whereas lesions of preoptic area of the hypothalamus suppressed
the response. They proposed that the OVLT may be the entry site of blood-borne IL-1

p into the brain leading to the preoptic area of the hypothalamus, which may contain the
neurons required for the ACTH response.
Finally, using antiserum directed against human IL-1 /j to stain the human brain
immunohistologically (34), IL-1 /j immunoreactive fibers were found in many areas of
the brain with a heavy innervation to the hypothalamus. Similarly, immunoreactive IL-1
/j also present in the hypothalamus and the extrahypothalamic regions of the rat brain

(136). The authors speculated that IL-1 may be an intrinsic neuromodulator in the central
pathways that may mediate neuroendocrine, febrile and many other responses. In vitro
production of IL-1, IL-6 and TNF by certain brain cells such as astrocytes and glial cells
in response to endotoxin challenge or viral infection have also been demonstrated
(138,200,215). Furthermore, in vivo production of those three cytokines in the brain or
CSF has also been demonstrated in a variety of infectious or inflammatory states
(82,95,105,135). For example, Fontana et al. (82) studied the in vivo synthesis of ILi/endogenous pyrogen within the brain of endotoxin treated mice. They found that IL-1
activity of brain extract, as determined by stimulating phytohemagglutinin (PHA)-initiated
proliferation of thymocytes, increased in a dose-dependent manner 5 hr after the injection
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of 50 µg endotoxin (i.p.). The enhanced IL-1 activity was first detectable 3 hr post
endotoxin. The febrile response induced by the brain extract was in accord with
temperature changes observed in purified IL-1 treated mice. A recent study by
Hallenbeck et al. (95) showed that the ICV injection of endotoxin (at doses of 1.8 and
3.6 mg/kg) induced a dose-dependent TNF production, as detected in the CSF. Elevated
mRNA expressions of IL-1, IL-6, and/or TNF in the rat brain particularly the
hypothalamus have also been observed in vivo following the central administration of
gamma-interferon and endotoxin, systemic injection of kainic acid, and immobilization
stress (102,160,161). Immobilization induced IL-1 mRNA was detected as early as 30
min after the start of the stress and reached a maximum at 60 min (161).

VI. Evidence for the Hypothalamus as the Potential Action Sites of Cytokines in the
Brain

Several authors have reported changes, either increases or decreases, in the
electrophysiological activity of hypothalamic neurons during the immune response
(23,205,216). Electrophoretically applied recombinant human IL-1 {3 (rhIL-1{3) and
rhTNF have also been shown to suppress the activity of glucose-sensitive neurons in the
rat lateral hypothalamic area and increase the neuronal activity of glucoreceptor neurons

in the rat ventromedial hypothalamic nucleus (180,194). Hypothalamic neurons could be
excited by interleukin-I in vitro (107). Enhanced hypothalamic norepinephrine
metabolism following the IL-1 treatment, either in vivo or in vitro, has also been
demonstrated (69,183,184,248). Direct injection of cytokines to different areas of the
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hYPothalamus induces a febrile response (27), hyperinsulinemia (55) and suppression of

food intake (194). In vitro incubation of the hypothalamus with either IL-1 or IL-6
stimulated CRF secretion (172,241). Therefore, the hypothalamus has been considered
to be one of the most important sites for cytokine actions.

As can be summarized from the cytokine review, many host defense responses to
infectious and inflammatory processes are mediated by cytokines via their central actions.
Some of the cytokine effects may be initiated in the brain side of the blood brain barrier,
particularly the hypothalamus. Relevant to the interest of the present dissertation study,
cytokines may act in the CNS, possibly the hypothalamus, to mediate the
sympathoadrenal activation during developing septic shock. However, these possibilities
have not been examined in a systematic manner, which will be the focus of another
project of the dissertation study.
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THE RATIONALE

Despite extensive demonstrations of the sympathoadrenal activation during
developing septic shock, mechanisms responsible for this activation are apparently
unknown and basically unexplored. After review of the limited and indirect data in the
literature, three themes might be suggested. First, major sympathoadrenal activation in
response to endotoxin challenge may be dependent on an intact CNS. Peripheral
modulation of epinephrine release from the adrenal gland might also make minor
contribution to the overall sympathoadrenal activation during endotoxicosis. Second,
afferent neural input from arterial baroreceptors may not have a dominant role in
mediating the sympathoadrenal activation in endotoxin shock. Third, interactions between
the immune-neuroendocrine systems exist with cytokines as likely mediators. This
interaction may also be applicable to the sympathetic response to endotoxic challenge
such that cytokines may mediate the sympathoadrenal activation during septic shock via
their central actions. However, these three aspects have never been studied directly, or
in a systematic manner. Thus, the presently proposed dissertation study will focus on
these potential mechanisms of sympathoadrenal activation in endotoxin shock. The
specific aims include: 1) to examine the overall contributions of central nervous system
as well as peripheral modulation (either neurogenic or non-neurogenic) to the
sympathoadrenal response in endotoxin shock, 2) to evaluate the role of afferent neural
input from the arterial baroreceptors in mediating sympathoadrenal activation during
endotoxic shock, and 3) to assess the central roles of three major cytokines, IL-1, IL-6
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and TNF, as mediators of the sympathoadrenal activation.

CHAPTER III

GENERAL MATERIALS AND METHODS

A. ANIMALS

Male, Holtzman rats, obtained from Harlan Sprague Dawley Inc. (Indianapolis),
weighing 300-500 g, were used in all experiments. The rats were housed in shoe box
cages with filter tops at least 1 week before use in order to recover from the stress of
shipping and to adjust to the new environment. Ambient temperature was approximately
22 °C to 25°C, and the illumination was controlled on 12 hr light-dark cycle. Wayne Lab.
Blox (full nutrient meal) and tap water were provided ad libitum except where indicated
prior to some experimental protocols.

B. CARDIOVASCULAR INSTRUMENTATION AND MEASUREMENTS

Arterial and venous cannulae were implanted either on the day of experiments for
acute preparations or the day prior to experiments for chronic preparations. These
cannulae permitted monitoring the hemodynamic changes (e.g. arterial blood pressure,
heart rate), collecting blood samples, or administering intravenous drugs throughout the
time course of experiments. In experiments with sinoaortic baroreceptor denervation,
femoral vessels rather than carotid arteries were cannulated to avoid any potential
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disturbances in the carotid sinus regions. In all other studies, carotid artery and jugular
vein cannulae were used.
For femoral vessel cannulation, a 1 cm long incision was made in the left inguinal
area. After exposure of the femoral vessels by blunt dissection, the arterial and venous
cannulae (PE-50 polyethylene tubing, Clay-Adams, NY), filled with heparinized saline
(100 U/ml), were inserted approximately 5 cm to the level of abdominal aorta and
inferior vena cava, respectively.
For carotid artery and jugular vein cannulation, a 2 cm ventral midline incision was
made in the neck and blunt dissection was employed to expose the vessels. The arterial
and venous cannulae were advanced approximately 3 cm to the level of the ascending
aorta and superior vena cava-right atrial junction, respectively.
In conscious rat experiments the ends of the cannulae were heat sealed, tunneled
under the skin, and were exteriorized through the back of the neck in the interscapular
region. The cannulated animals were then placed one per cage to prevent damage to the
cannulae and fasted for about 24 hrs with free access to water.
Prior to the onset of experimentation, the arterial cannula was extended to a saline-

filled Statham pressure transducer (model P23) via a tygon tubing adaptor and additional
PE-50 tubing. Pulsatile as well as mean blood pressures (MBP) were monitored
continuously using a Grass oscillograph (model 7). The heart rate (HR) was determined
from the pressure pulses. Extension of the venous line provided a convenient means for
intravenous drug administration and replacing volume for blood sampling. Care was
taken to minimize heparin administration to each rat during experiments by withdrawing

41
the heparinized saline before flushing the cannula with non-heparinized saline. Before
beginning each experiment, rats were allowed time (approximately 30 min) to become
acclimatized to their environment as determined by normal, steady mean arterial blood
pressures (approximately 90-120 mmHg) and heart rates (approximately 300-400
beats/min) as well as by quiet behavior.

c.

Sinoaortic Baroreceptor Denervation
Sinoaortic baroreceptor denervation (SAD) was performed by a modification of the

method originally described by Krieger (133). Anesthetized animals were placed in a
supine position on a warm pad. Using aseptic technique, a midline incision (2.5-3 cm)
was made in the neck and the neurovascular sheath enclosing the common carotid
arteries, the vagi, and the cervical sympathetic nerve trunks were exposed by retracting
the sternohyoid and sternomastoid muscles. The vagi were carefully separated from the
neurovascular sheath with the aid of a dissecting microscope (0. 7x-3x, Bausch & Lomb
Inc.). For aortic baroreceptor denervation, the superior laryngeal nerves were cut near
the vagi and the superior cervical ganglia including a small segment of the sympathetic
chain were removed to prevent the possibility of reconnection. Aortic depressor nerves,
usually found associated with the sympathetic trunk, were sectioned when evident. For
carotid sinus denervation, the area of the carotid bifurcation was widely exposed. All
connective tissue and nerve fibers were stripped from the thyroid, occipital, internal,
external and common carotid arteries. Extra care was taken to prevent injury of vagal
nerves. Sham operations were performed by exposing the carotid sinuses bilaterally
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without dissection of the region. Bilateral sinoaortic denervation was normally performed
in a one-stage operation lasting approximately 30 min. In chronic SAD and sham

preparations, animals received 40,000 IU penicillin (i.m.) following the surgery and were
allowed 2-4 weeks for recovery.
Completeness of the baroreceptor denervation was tested by determining the
magnitude of the reflex bradycardia in response to phenylephrine-induced hypertension
(4 µglkg, i. v.) and the reflex tachycardia in response to nitroglycerine-induced
hypotension (0.5 µglkg, i.v.). Such observations have been routinely used as the criteria
of the effectiveness of the SAD (8,13,169,239). Only those animals which exhibited a
reflex bradycardia of < 20 beats/minute and a reflex tachycardia of < 20 beats/minute
in response to 40-50 mmHg change in MBP were accepted as SAD rats (8). The
bradycardia or tachycardia typically observed in sham controls was 60-120 beats/min
after the same dose of phenylephrine or nitroglycerine.

D. SYMPATHETIC NERVE RECORDINGS
Renal sympathetic nerve activity (RSNA) was recorded from a renal branch of the
left greater splanchnic nerve (61,185). Using aseptic techniques, the left kidney was
exposed retroperitoneally through a flank incision. The renal nerve branch was usually
found in the aortic-renal artery angle, coursing to the renal vascular pedicle through the
perirenal fat and into the hilus of the kidney. Under a dissection microscope, the renal
nerve was gently separated from fat and connective tissues, and carefully placed on a
thin, bipolar gold electrode hook. The gold electrodes were teflon-coated with one end
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bared, bent to a hook, and the other end connected to extension cables. When an optimal
nerve signal was obtained, the electrode and the nerve were fixed with a mixture of equal
parts of dental elastomeric impression material base, catalyst (both from Sybron-Kerr,
Romulus, MI), and RTV silicon gel base (Petrarch Systems Inc., Bristol, PA). After
closure of the incision in layers, the electrode cables were tunnelled subcutaneously and
exteriorized on the back of the neck.
On the next day, the electrode cables were extended to an amplifier while the
conscious rats were in cages. The nerve signal was amplified 1,000-10,000 fold and
filtered (low-frequency cutoff at 35 Hz and high-frequency cutoff at 2,000 Hz) by a
Grass model HIP511A pre-amplifier and a Grass model P511R amplifier. The amplified
signal was continuously displayed on an oscilloscope (Tektronix Inc., Type 561A) and
led to an audio amplifier/loud speaker (Grass AM?). Representative oscilloscope displays
of amplified raw renal sympathetic nerve activity from unrestrained, conscious rats are
shown in figure 3-1. For estimation of frequencies of RSNA, the signal was full-wave
rectified and integrated by a Grass model 7P3A integrator with a time constant 0.02 sec
and the spikes/min were measured. For simultaneous estimation of overall RSNA, which
involves both frequencies of RSNA and amplitudes of RSNA spikes, the amplified signal
was also rectified and integrated by a Grass model 7P10E integrator and the slopes of
integration were determined. In both cases, the rectified-integrated signal was
continuously recorded using a Grass oscillograph (model 7).
The background noise level for the nerve recording was determined 30 min after
each animal was euthanized with i. v. pentobarbital overdose. For RSNA spike
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50 msec/division

Figure 3-1.0scilloscope display of amplified raw renal sympathetic nerve activity from
unrestrained, conscious rats.
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measurement, only spikes with amplitudes greater than background noise level were
counted. For slope measurement, background noise slope was subtracted from the mean
rectified nerve signal slope obtained in the living animal. All RSNA were sampled for
20 sec at indicated sampling times and expressed as percent change from baseline
control. Percent changes of RSNA were used because the absolute value of multiunit
activity is influenced by recording conditions that vary between different preparations.
Such variations include the spatial relationship of the nerve fibers to the electrodes and
the amount of tissue fluid around each nerve.

E. IMPLANTATION OF INTRACEREBROVENTRICULAR (ICV) CANNULA
Anesthetized rats were placed in a stereotaxic apparatus (Trent H. Wells Jr.
Mechanical Developments Co. South Gate, CA) in a prone position. A 2 cm midline
incision was made on the skull and the bregma was exposed. After determining the
coordinates for the right lateral ventricle using the bregma as a reference point, a small
hole (0.5 mm diameter) was made with an electric drill. A 30 gauge stainless steel
cannula was inserted through the hole in the skull into the lateral ventricle with the tip
coordinates: 0.5 mm caudal to bregma, 1.5 mm lateral to the midline, and 4.5 mm below
the surface of the skull (10). The end of the cannula was pre-bent to a right angle and
connected to a piece of PE-10 tubing (5 cm long), filled with saline (3-4 µl) and heat
sealed. Two stainless steel anchoring screws were fixed on the skull, and the cannula
secured in place by dental acrylic cement. The incision was sutured with the end of the
PE-10 tubing exteriorized. On the day of experiment, the cannula was connected to a 10
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µI Hamilton microsyringe filled with test solution. A 10 µl test solution (plus 3-4 µl

saline in the cannula) was infused over a period of 5 min.
At the end of each experiment, methylene blue dye solution (15 µl) was injected via
the cannula. The animals were sacrificed with pentobarbital overdose (i.v.), and the
brains were removed. The exact location of the injection was verified. Only those
animals with successful ICV injections, as indicated by staining of the lateral ventricles,
were included in the data analysis.

F. IMPLANTATION OF CANNULAE INTO THE PARAVENTRICULAR NUCLEUS
OF THE HYPOTHALAMUS (PVN)
Cannulae for injections into the paraventricular nucleus of the hypothalamus (PVN)
were implanted using a stereotaxic apparatus. After exposure of the bregma under
anesthesia, a 3 mm x 1 mm slot was prepared across the midsagittal suture on the skull
with a electric drill. A bilateral guide cannula (Plastic One Inc., Roanoke, VA),
constructed of two 26-gauge stainless steel tubes with a 1. 0 mm distance between the
centers, was implanted in the bilateral PVN through the slot in the skull. The coordinates
for this position were: 1. 7 mm caudal to the bregma, 0.5 mm lateral to the midsagital
suture, and 8.0 mm ventral to the skull surface with the incisor bar set at 4.0 mm below
the interaural line (190). Four stainless steel anchoring screws were fixed on the skull,
and the cannula secured in place with dental acrylic cement. The incision was closed with
a suture. A dummy wire with two leads was inserted into the guide cannula to prevent
clotting in the cannula and also prevent dust from getting into the cannula. On the day
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of experiments, the dummy wires were removed and a double injector cannula (33 gauge,
Plastic One Inc.), which was 2 mm longer than the guide cannula, was inserted into the
guide cannula. The injector cannula, filled with test solution, was connected to a 10 µI
Hamilton microsyringe via a flexible tygon tubing (same size as PE-10, Norton Tubing
and Molded Products, Akron, OH). Testing solution (500 nl) was injected bilaterally over
a 5 min period. The volume of an injection was monitored by observing the movement
of a small bubble through a calibrated distance in the tubing.
For histological verification of the injection site, pentobarbital-treated animals were
perfused transcardially with 10% buffered formalin, and their brains were removed and
preserved in buffered formalin for at least 48 hrs. The brains were then cut on a cryostat
(40 µm sections) and stained by the cresyl violet method to verify the position of the
cannula tip. Only those animals in which the cannulae terminated in the dorsal border of
the PVN without damage to the PVN neurons were included in the statistical evaluation.

G. PITHING PROCEDURES
Pithed rats were prepared according to the method of Gillespie and Muir (85). The
animals were anesthetized with ether, and the trachea cannulated. An aluminum pithing
rod (2 mm diameter) was passed into the brain through the right orbit and advanced
down the spinal cord to the sacral vertebrae for a total distance of 15 cm. The rats were
immediately ventilated with Harvard Apparatus Rodent respirator (room air, 60
strokes/min, approximately 1-1.2 ml/100 g body weight). Rectal temperature was
maintained at 36-37 °C with a heating pad and a lamp. The pithing rod served as a
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stimulating electrode, and another rod was inserted under the skin of the back to serve
as an indifferent electrode for stimulation of the spinal cord. This pithing procedure
destroys the entire central nervous system, but leaves the emerging nerve trunks intact.
Since those parts of the pithing rod in the sacral and cervical regions of the spinal cord
were coated with high resistance varnish, the stimulating current applied through the
pithing rod was restricted to the thoracolumbar region where the sympathetic
preganglionic fibers are located. After curare (3 mg/kg) was given via the dorsal vein of
the penis to eliminate skeletal muscle contractions, the preganglionic thoraco-lumbar
sympathetic nerves were stimulated at a constant rate (3 Hz, 10 V, and 0.5 msec) to
maintain blood pressure at physiological levels. Some rats required small supplemental
doses of curare.
The advantages of using pithing combined with stimulation include: 1) sympathetic
outflow can be maintained at a steady level by applying a constant stimulation to the
sympathetic preganglionic fibers via the pithing rod, 2) basal blood pressure can be
maintained at physiological levels, and 3) there are no centrally-mediated compensations.
By using this model, the CNS mediated fluctuation in catecholamine release from the
nerve terminals and the adrenal medulla is eliminated, thus, allowing the evaluation of
the peripheral mechanisms of catecholamine release.

H. ADRENAL GLAND DENERVATION

Rats were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). Under aseptic
conditions, two flank incisions were made on both left and right sides of the back just
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below the costal margin. With the aid of a microscope, the adrenal glands were isolated
from the surrounding connective tissues except for the adrenal artery and vein. The
splanchnic nerve fibers innervating the adrenal gland and any other fibers which might
enter the adrenals without joining the splanchnic nerves were served. Extra care was
taken to leave the vessels intact to avoid necrotic damage to the adrenal glands. Phenol
(10%) was then applied on the surface of the glands and the vessels. Sham operations
were performed by exposing the adrenal glands without dissecting the nerves. The
incisions were closed in layers, and rats received 40,000 IU penicillin (i.m.). The
denervation procedure required about 20 min to complete, and a two week recovery
period was allowed before the experiment.
The effectiveness of this adrenal denervation technique was verified in a separate
group by demonstrating the failure of plasma epinephrine to become elevated in response
to hemorrhage. Chronic adrenal denervated rats were subject to carotid artery cannulation
and on the next day, the carotid cannula was extended to a 5 ml glass syringe via a PE200 tubing, both pre-rinsed with heparin. The syringe served as a blood reservoir and
blood was allowed to flow in or out of the reservoir depending on the height of the
syringe above the rat. The blood pressure was monitored on the Grass oscillograph using
a stopcock. The rats were bled to 70 mmHg (total volume 4.5-5 ml) in about 10 min by
adjusting the syringe position. Blood samples were taken at predetemined times (15, 60
min) for catecholamine assay. Results showed that in sham denervated rats (n=3),
hemorrhage induced significant elevations in plasma epinephrine (251 +60 pg/ml at 0

min, 2286+465 pg/ml at 60 min) and norepinephrine (377+44 pg/ml at 0 min, 787+204
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at 60 min). In contrast, plasma epinephrine elevations were abolished in adrenal
denervated rats (n=3, 45+16 pg/ml at O min, 48+7 pg/ml at 60 min) while plasma
norepinephrine was still increased (394+ 102 pg/ml at O min, 764+75 pg/ml at 60 min)
in response to hemorrhage.

I. BLOOD SAMPLE COLLECTION

Arterial blood samples (500 µl) were collected at predetermined times and placed
in 1.5 microcentrifuge tubes (Sarstedt) containing 10 µl solution consisting of 90 mg/ml

ethyleneglycol-bis-(B-amino-ethyl ether)N,N'-tetraacetic acid (EGTA) and 60 mg/ml
glutathione (pH 6-7). The plasma was separated following centrifugation (10,000 g x 2-3
min, Eppendorf Model 5414 microfuge) and stored at -40 °C (Revco freezer) until
analysis for catecholamines. A 500 µl volume of donor blood from normal rats or equal
volume of saline-resuspended blood cells was infused into the venous line following each
sample withdrawal.

J. PLASMA CATECHOLAMINE ASSAY

Plasma levels of norepinephrine and epinephrine were assayed according to the
radio-enzymatic thin-layer chromatographic procedure described previously (189,193).
Materials were supplied in kit form (Amersham, Arlington Heights, IL). This single
isotope radioenzymatic

method can

measure epinephrine and

norepinephrine

simultaneously with a sensitivity of 2-5 pg per 50 µl sample (40-100 pg/ml plasma) and
interassay variation of approximately 10%. The analysis is based on the use of the
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isolated enzyme catecholamine-o-methyltransferase (COMT) to transfer a radioactive
methyl group from S-adenosyl-L-methionine (3H-SAM) to an endogenous catecholamine
acceptor molecule to form a O-methylcatecholamine derivative. In the presence of 3HSAM, epinephrine is converted to 3H-metanephrine and norepinephrine is converted to
H-normetanephrine.

3

Duplicate 50 µl aliquots of each plasma sample were added to incubates containing
(in final concentration) 100 mM Tris, 30 mM MgC12 , 10 mM EGTA, 10 µl of COMT
solution, 1 mM reduced glutathione, 5 µCi SAM (3H-methyl, 4.3-5.5 mM). Total volume
was 100 µland pH was approximately 8.1-8.3. For every 5 samples, one sample was
added to four tubes rather than duplicate tubes and 100 pg of epinephrine and
norepinephrine were added to two of the four tubes as internal standards. Reagent blank
was constituted by substituting distilled H2O for the plasma.
The samples were incubated in a shaking water bath at 37 °C for 60 min. The
reaction was stopped by addition of 50 µl of a solution consisting of 800 mM boric acid,
80 mM ethylenediamine tetraacetic acid-disodium salt (EDTA-Na2) and 4 mM each of
metanephrine and normetanephrine in 1 NaOH. The resulting solution (pH 10.0) was
mixed vigorously for 15 sec with 2 ml of toluene/isoamyl alcohol (3:2, v:v). The 3Hmethoxycatecholamine derivatives are much more soluble in the organic phase than in
aqueous phase. The aqueous and organic phases were separated by centrifugation (800
g x 2 min, Model UV centrifuge, International Equipment Company). The aqueous phase
was rapidly frozen in an ethanol/dry ice bath, and the organic phase was decanted into
a tube containing 100 µl of 0.1 M acetic acid. The 3H-methylcatecholamine derivatives

52
were partitioned into the aqueous phase by mixing for 15 sec. The decrease in pH
effected by the addition of acetic acid greatly reduced the solubility of the derivatives in
the organic phase. After the tubes were centrifuged at 800 g for 2 min, the aqueous
phase was quick-frozen, and the organic phase was discarded. One ml of the tolueneisoamyl alcohol was added to the acetic acid mixture. After mixing, centrifugation and
freezing the aqueous phase, the organic layers were aspirated and discarded. One
hundred µl of ethanol was then added to the final extract and the solution was applied to
a silica gel thin glass plate (Uniplate, Analtech) by use of 250 µl Hamilton syringes and
a thin layer chromatograph (TLC) Multispotter (Analytical Instrumentation Specialties)
while drying with a hot air blow dryer (60 °C). The plates were developed for 20-30 min
in a paper-lined tank containing a solution of chloroform/t-amyl alcohol/methylamine
(8/2/1, v/v/v). Two zones were visualized under 254 nm UV light. The upper zone
contained metanephrine, and the lower zone contained normetanephrine. Each zone was
then scraped from the plate into a correspondingly numbered scintillation vial.
The further steps for epinephrine and norepinephrine assay were identical. One ml
of0.05 M ammonium hydroxide was added to each vial to elute the amine from the silica
gel. The 3H-catecholamine derivative was then oxidized to 3H-vanillin by addition of 50
µl of sodium periodate for 5 min followed by the addition of 500 µl of 10% glycerol.
The solution was acidified by the addition of 1 ml of 0.1 M acetic acid and vigorously
mixing. Ten ml of toluene/liquiflor (1000:50) was added to each vial and 3H-vanillin was
partitioned into the organic phase with 30 sec shaking. Liquiflor is a 2.5Diphenyloxazole--p-bis-[2-(5-phenyloxazolyl)]-benzene

(PPO-POPPO)

toluene
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concentrate. Radioactivity in these samples was determined by a liquid scintillation
counter (LKB Instruments Inc., MD). The sample plasma content for each catecholamine
was calculated by computer using the following equation:
catecholamine Concentration (pg/ml)=
CPM sample-CPM blank

pg standard

X
CPM (sample+standard)-CPM sample

ml sample volume

Above counts per min (CPM) value was the average from each set of duplicates.

K. AGENTS
1. Endotoxin {ETX): Lyophilized endotoxin derived from Salmonella enteritidis

(lipopolysaccharide Boivin, control No. 723198) was purchased from Difeo Laboratories
(Detroit, Ml). For use in intravenous administration, the lipopolysaccharide was prepared
freshly in 0.9% sodium chloride (3 mg/ml for the dose of 5 mg/kg, and 1 mg/ml for the
dose of 1.5 mg/kg).
2. Interleukin-IP (IL-1/j): Human recombinant interleukin-1/j was purchased in a
lyophilized form from Biosource International Inc. (Westlake Village, CA). The IL-1 was
lot 215-llOC with specific activity 1 x107 unit/mg, as assessed by a mitogenic assay
stimulating 3H-thymidine uptake into C3H/HFJ thymocytes. Endotoxin contamination was
determined by Biosource to be less than 0.001 endotoxin units/µg (Limulus Amoebocyte
Lystate Assay; 1 endotoxin unit = 0.1 ng of ETX).
3. Interleukin-6 (IL-6): Human recombinant interleukin-6 was obtained in a lyophilized
form from Biosource International Inc. (Westlake Village, CA). The lot No. was 216-
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0()2D, and the specific activity was 6 x 1()6 unit/mg as determined by stimulation of 3Htbymidine uptake by B9 cells. Endotoxin contamination was same as in IL-1.
4. Tumor necrosis factor a (TNFa): Human recombinant tumor necrosis factor a was
also purchased in a lyophilized form from Biosource International Inc. (Westlake Village,
CA). The lot No. was 311-010D, and the specific activity was 1 x 1()8 unit/mg as
determined by the cytolysis of murine L929 cells in the presence of Actinomycin-D.
Endotoxin contamination was also less than 0.001 endotoxin units/µg.

L. DATA ANALYSIS
Data are expressed as mean+SEM. A p value less than 0.05 was considered to be
statistically significant. Cardiovascular responses, percent change of sympathetic nerve
activity and plasma catecholamines following test treatments were compared using
analysis of variance with repeated measurements. Student-Newman-Keul's test was used
for individual group comparisons. Blood pressure and associated heart rate as well as
RSNA responses to phenylephrine or nitroglycerine infusion to assess baroreceptor
denervation were compared between the SAD and sham groups with unpaired Student t
tests.

CHAPTER IV

INVOLVEMENT OF CENTRAL VS. PERIPHERAL MECHANISMS
IN MEDIATING SYMPATHOADRENAL ACTIVATION IN ENDOTOXIC RATS

INTRODUCTION

Gram-negative sepsis with ensuing septic shock is a persistent health problem
accounting for the major cause of mortality in hospitalized patients (1,32). Numerous
studies have linked gram-negative bacterial endotoxins to the pathogenesis of sepsis
(103,104,167,171), which supports the use of the endotoxic animal model for studying
the basic pathophysiologic process of septic shock.
Studies of sepsis or endotoxicosis in either clinical or experimental situations have
demonstrated a marked sympathoadrenal activation. Supportive evidence includes
elevations of plasma catecholamines ( 17, 94, 113, 114, 134), an enhanced norepinephrine
turnover (188), augmented sympathetic nerve discharges (92,159,185) as well as
depletion of the tissue catecholamine content in the end stage of septic shock (96,187).
This sympathoadrenal activation may support the cardiovascular and metabolic
adjustments to septic challenge, but overwhelming and sustained activation may
contribute to the irreversibility of the shock process (31, 88, 125, 148).
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Mechanisms responsible for mediating the sympathoadrenal activation during
endotoxicosis are largely unknown. Norepinephrine release from the sympathetic nerve
terminals and epinephrine release from the adrenal medulla are most likely neurallycontrolled via post ganglionic sympathetic nerves and preganglionic adrenal sympathetic
nerves, respectively. The critical role of centrally-mediated mechanisms and neural
dependence of the sympathetic activation during developing endotoxic shock have been
demonstrated in previous studies (71,150,176,253). However, recent experimental
findings suggest that peripheral modulation of catecholamine secretion from the adrenal
medulla during endotoxic shock may also be present (112,211). Non-neurogenic
stimulation of adrenal epinephrine secretion is suggested by evidence that ganglionic
blockade could not prevent catecholamine release from the adrenal medulla (211), and

in vitro incubation of adrenal chromaffin cells with endotoxin or other endotoxinelaborated agents enhance catecholamine secretion (130,141,177,225).
Thus, the purposes of the present study were: 1) to clarify whether both central and
peripheral mechanisms are involved in mediating plasma catecholamine responses during
endotoxicosis, 2) to assess the relative contributions of each of the mechanisms to
elevations in plasma norepinephrine and epinephrine following endotoxic challenge, and
3) to examine the neurogenic or non-neurogenic characteristics of peripheral modulations
of adrenomedullary release following endotoxin, if the modulation indeed exists.
Specifically, plasma catecholamine responses to endotoxin challenge were compared
between rats with and without central regulatory mechanisms, i.e. conscious and pithed
rats, to assess the contribution of central mechanisms. It was hypothesized that the major
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elevation of plasma catecholamines depends on centrally-mediated mechanisms such that
destruction of the central nervous system (by pithing) would significantly diminish the
endotoxin-induced elevation in plasma catecholamines. Meanwhile, pithed rats with
constant stimulations of the sympathetic chain do not have centrally-mediated fluctuations

in sympathetic outflow and, thus, permit the evaluation of peripheral modulation of
catecholamine release. It was hypothesized that peripheral modulations of the adrenal
medulla are present, which would result in significant elevation of plasma epinephrine

in pithed rats following administration of endotoxin. The possibility of non-neurogenic
catecholamine secretion from the adrenal gland was further studied in pithed animals as
well as conscious rats by means of adrenal denervation.
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MATERIALS AND METHODS

Experimental Protocols
Two sets of experiments were conducted in male rats weighing 407+ 10 grams. In
the first experiment sympathoadrenal responses were assessed in pithed, endotoxic rats
with intact or denervated adrenal glands. Under pentobarbital anesthesia, bilateral adrenal
glands were denervated or sham-operated and penicillin (40,000 JU) was given i.m.
following the surgery. After two weeks of recovery, experiments were performed. Rats
were pithed under ether anesthesia and immediately ventilated (60 strokes/min, 1-1.2
ml/100 g body weight). After administration of curare, the thoraco-lumbar preganglionic
sympathetic nerve fibers were stimulated at a constant rate (3 Hz, 10 V, and 0.5 msec).
Carotid artery and jugular vein were then cannulated. Following a 30 min equilibration
period, endotoxin (1.5 mg/kg) was given intravenously to both adrenal sham-operated
rats (n=8) and adrenal denervated rats (n=7). Saline treated sham (n=5) and adrenal
denervated (n=4) rats served as controls. The hemodynamic response was assessed at
0, 30, 60 and 90 min, and plasma catecholamines were determined at 0, 60 and 90 min
post endotoxin. Rectal temperature was maintained at 36-37 °C using a heating pad and
a lamp throughout the protocol.

In the second experiment sympathoadrenal responses were evaluated in conscious
rats with intact or denervated adrenal glands. Under halothane anesthesia chronically
adrenal sham-operated or denervated rats underwent implantation of arterial and venous
cannulae, and experiments were conducted the following day. Endotoxin was given
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intravenously (1.5 mg/ml) to both sham operated (n=5) and denervated rats (n=5).
saline treated sham {n=5) and denervated {n=4) rats served as controls. Hemodynamic
responses and plasma catecholamines were also assessed at 0, 30, 60, and 90 min post
endotoxin.

Pithing Procedures
Pithed rats were prepared according to the method described in chapter III. Briefly,
after cannulation of the trachea under ether anesthesia, rats were pithed by inserting an
aluminum rod through the orbit and foramen magnum, down the spinal cord to the sacral
vertebrae. The pithing rod served as a stimulating electrode, and another rod inserted
under the back skin served as an indifferent electrode for stimulation of the sympathetic
chain. After minimizing skeletal muscle contraction with curare (3 mg/kg, i.v.), the
preganglionic thoraco-lumbar sympathetic nerves were stimulated at a constant rate (3
Hz, 10 V, and 0.5 msec) to maintain blood pressure at physiological levels and to
eliminate the fluctuations of catecholamine secretions.

Adrenal Gland Denervation
As described in general methods, bilateral adrenal glands were denervated by
severing all the surrounding connective tissues which contain the nerve fibers innervating
the adrenals. Extra care was taken to leave the blood vessels intact to avoid necrotic
damage to the adrenal glands. Phenol (10%) was then applied on the surface of the
glands and the vessels. Sham operations were performed by exposing the adrenal glands
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without dissecting the nerves. Two week recovery period was allowed before
experiments. The effectiveness of this adrenal denervation technique was verified, in a
separate group, by demonstrating the failure of the plasma epinephrine elevation in
response to hemorrhage-induced hypotension (see Chapter III for details).

Blood Sample Collection and Catecholamine Assay
Arterial blood samples (500 µl) were collected at pre-determined times and treated
as described in chapter III. A 500 µl volume of donor blood from normal rats was
infused into the venous line following each sample withdrawal. Plasma levels of
norepinephrine and epinephrine were assayed in duplicate 50 µl samples using the radioenzymatic thin-layer chromatographic procedure described in general methods.

Materials
Endotoxin (derived from S. enteritidis) was prepared freshly in 0.9% saline (1
mg/ml). Materials for catecholamine assay were obtained in kit form from Amersham
(Arlington Heights, IL).

Data Analysis
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to
be statistically significant. Cardiovascular responses and plasma catecholamines were
compared using analysis of variance with repeated measurements and Student-NewmanKeul 's test for individual comparisons.
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RESULTS

Hemodynamic and Sympathetic Responses in Pithed Rats Following Endotoxin
Thirty minutes after pithing, arterial blood pressure and heart rate in all animals
with constant stimulation reached steady-state levels. As presented in figure 4-1, baseline
mean blood pressure were not different between the groups. The mean blood pressure
was within physiological range (100-120 mmHg), indicating that this level of electrical
stimulation to the sympathetic chain was adequate to maintain the blood pressure in
pithed rats comparable to levels in conscious rats. There was a gradual decline of the
blood pressure with time in saline treated animals, as indicated in figure 4-1 where MBP
was decreased from baseline value of 110+ 10 to 88+6 mmHg at 90 min in sham rats
and 99 + 3 to 87 + 10 mmHg in denervated rats. By contrast, in both adrenal sham
operated and denervated rats, intravenous endotoxin treatment induced much greater drop
in MBP than the time-related fall. The decrease in MBP was similar in sham and
denervated groups given endotoxin, from pretreatment values of 107+4 and 117+5
mmHg to 42+3 and 41 +4 mmHg at 90 min, respectively. There were no differences in
baseline heart rate between the groups. Heart rate was significantly accelerated to
comparable levels at 60 and 90 min following endotoxin injection in sham and denervated
rats. Saline treatment did not affect the heart rate during the protocol.
In both adrenal sham-operated and denervated animals, plasma norepinephrine was
not significantly elevated by endotoxin administration during the 90 min protocol
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Figure 4-1.Mean blood pressure (MBP) and heart rate (HR) responses in pithed rats with
adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) following
intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p<0.05 for both ADR DENERY
and ADR SHAM post endotoxin vs. 0 min; $: p < 0.05 for both ADR DENERY and
ADR SHAM post saline vs. 0 min.
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(figure 4-2). In contrast, intravenous endotoxin induced mild and similar increase in
plasma epinephrine in both sham and denervated groups. Ninety min after endotoxin
injection, plasma epinephrine was increased from pretreatment value of 153+ 19 and
125+38 to 376+87 and 463+ 137 pg/ml in sham and denervated groups, respectively.
Saline treatment in sham and denervated animals altered neither plasma norepinephrine
nor epinephrine.

Hemodynamic and Sympathetic Responses in Conscious Rats Following Endotoxin
In conscious sham-operated animals, intravenous endotoxin induced a significant
drop in blood pressure at 60 min post treatment, which recovered at 90 min to a level
not different from the baseline value (figure 4-3). In adrenal denervated conscious rats,
however, hypotension appeared at 30 min following endotoxin injection, which was
significantly lower compared to MBP in the sham group. Furthermore, the denervated
animals remained in a hypotensive state thereafter with slight recovery at 90 min. In both
sham and denervated groups, endotoxin treatment evoked a significant tachycardia as
indicated in figure 4-3 at 30, 60 and 90 min post injection. The heart rate was
significantly higher in denervated rats at 60 min in comparison to sham animals. Saline
controls of both sham and denervated rats showed no alterations in MBP and heart rate.
Plasma catecholamine response to endotoxin challenge in conscious rats is presented
m figure 4-4. In both adrenal sham-operated and denervated animals, plasma
norepinephrine was similarly and significantly enhanced from baseline values
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Figure 4-2. Plasma norepinephrine (NE) and epinephrine (EPI) responses in pithed rats
with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM) following
intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p < 0.05 both ADR DENERY and
ADR SHAM post endotoxin vs. 0 min.
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Figure 4-3. Mean blood pressure (MBP) and heart rate (HR) responses in conscious
rats with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM)
following intravenous endotoxin (ETX, 1.5 mg/kg) or saline. *: p < 0.05 for ADR
DENERY post endotoxin vs. 0 min;#: p<0.05 for ADR SHAM post endotoxin vs. 0
min; +: p<0.05 for endotoxin-treated ADR DENERY vs. ADR SHAM.
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following endotoxin throughout the 90 min protocol. Although the norepinephrine level
at 90 min in denervated group appeared to be higher than that in the sham group, the
multivariate ANOV A with repeated measures did not indicate a significant difference,
most likely due to the high variance in the denervated group. The response pattern of
plasma epinephrine was dramatically different between the sham group and the
denervated group. As shown in figure 4-4, in sham animals, plasma epinephrine was
markedly elevated at 30 min following endotoxin and remain elevated thereafter. The
maximum increment, approximately 12-13 fold above control, was achieved 30-60 min
post endotoxin after which the increase diminished, but remained 4 fold higher than
baseline value at 90 min. In contrast, in adrenal denervated rats, the same dose of
endotoxin did not induce significant enhancement of plasma epinephrine until 90 min post
injection where the increment was not different from that in sham rats. Saline treatment
to both sham and denervated animals did not have any significant effects on plasma
catecholamines during the protocol.
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Figure 4-4. Plasma norepinephrine (NE) and epinephrine (EPI) responses in conscious
rats with adrenal denervation (ADR DENERY) or sham operation (ADR SHAM)
following intravenous endotoxin (ETX, 1.5 mg/kg) or saline. x: p < 0.05 for both ADR
DENERY and ADR SHAM post endotoxin vs. 0 min;*: p<0.05 for ADR DENERY
post endotoxin vs. 0 min; #: p < 0.05 for ADR SHAM post endotoxin vs. 0 min; +:
p<0.05 for endotoxin-treated ADR DENERY vs. ADR SHAM.
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DISCUSSION

The data presented in this study demonstrated that in pithed rats with no central
regulatory mechanisms, intravenous endotoxin did not increase plasma norepinephrine
during the 90 min protocol. However, endotoxin administration did induce a 2 to 3 fold
elevation in plasma epinephrine at 90 min post injection. In contrast, data from the
present and previous studies (114) showed that in intact conscious rats, both plasma
norepinephrine and epinephrine were markedly elevated 30 min following endotoxin
(figure 4-4). Thereafter, plasma norepinephrine remained elevated, and epinephrine
declined gradually but was still significantly above pre-treatment controls. These results
suggest that increases in plasma norepinephrine during endotoxicosis, largely elaborated
from sympathetic nerve terminals, depend on central mechanisms. Increases in plasma
epinephrine with endotoxin, primarily released from the adrenal medulla, were shown
to involve both central and peripheral regulations with central mechanism being
dominant. This is demonstrated by the much lower and delayed elevation of plasma
epinephrine in pithed rats (figure 4-2) compared to conscious rats following endotoxin
(figure 4-4). Since endotoxin induced a similar elevation in plasma epinephrine in pithed
rats both with and without adrenal innervation, it appears that peripheral mechanisms
involve non-neurogenic modulation of release. This non-neurogenic adrenal epinephrine
release was further substantiated in conscious, adrenal denervated rats, which accounted
for 1/3 of the maximum epinephrine response as observed in intact rats (figure 4-4).
Consistent with the finding in pithed rats, the epinephrine elevation in adrenal denervated

69
conscious rats also showed a lower magnitude and a delayed time course compared to
intact animals. These results imply that central mechanisms are primarily responsible for
the early epinephrine increments during endotoxicosis whereas the peripheral modulation
contributes to the more prolonged plasma epinephrine elevation.
The present results are in agreement with previous reports where the crucial
involvement of the central nervous system in the sympathoadrenal response during
endotoxicosis was demonstrated. For example, acute lesion of the cerebellar fastigial
nuclei in the dog prevents the recovery and maintenance of blood pressure following
endotoxin-induced hypotension (149), suggesting that the sympathetic response to
endotoxin challenge requires intact central regulatory mechanisms. Intact spinal cord also
seems critical to endotoxin-evoked sympathetic response. Spinal transection at the C-7
level in dogs abolished the catecholamine release during endotoxicosis (71), implying that
endotoxin-elicited sympathoadrenal response was presumably dependent on descending
spinal pathways. Section of the splanchnic nerves in the dog eliminated the elevation of
plasma epinephrine (176), and acute denervation of hemi-spleen protected against the
norepinephrine depletion (253). These results suggest that increased catecholamine release
during septic shock depends on nerve activation.
Unlike the present study, these authors did not report the non-neurogenic modulation
of epinephrine release from the adrenal glands. This may be attributable to the fact that
animals species, doses of endotoxin and sampling time course used in the present study
and previous studies are different. Most importantly, it is noteworthy that the animal
numbers in the previous studies were small (n=2-3) and the results were variable.
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Furthermore, the catecholamine assay used in their studies (biological or floremetric
assay) was less sensitive.
The peripheral modulation of epinephrine secretion has been previously reported in
pithed, endotoxic rats (112), but it was not known whether this modulation was neurally
or non-neurally mediated. In both previous and present studies using pithed rats,
sympathetic outflow to the adrenal glands was maintained at steady state levels by
applying constant electrical stimulation to the paravertebral sympathetic chain. In those
animals endotoxin-induced adrenal modulation could be due to an enhanced epinephrine
release per nerve impulse or local modulation within the glands independent of nerve
activity. The data from adrenal denervated rats in the present study suggest that such
peripheral modulation is most likely non-neurogenic. Although incomplete adrenal
denervation could account for epinephrine elevation with endotoxin, this is unlikely to
be the case in the present study. First, the adrenal denervation completely abolished the
increases in plasma epinephrine in response to hemorrhage-induced hypotension.
Secondly, 90 min following endotoxin, adrenal denervated animals showed similar, rather
than attenuated, epinephrine response compared to adrenal intact animals. The nonneurogenic stimulation of the adrenal epinephrine secretion has also been reported in a
previous study in that ganglionic blockade could not prevent catecholamine release from
the adrenal glands during endotoxicosis in newborn rats (211).
One possible mechanism for the endotoxin-mediated non-neurogenic release may
involve decreased oxygen supply to the adrenal medulla as a consequence of circulatory
hypoxia and diminished blood flow. Hypoxia has been shown to be a potent stimulus for
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adrenal catecholamine secretion in newborn rats (212), but in adult rats hypoxia effects
are not prominent on catecholamine release from the adrenal gland (212). Alternatively,
certain endogenous substances released into the circulation during endotoxicosis have also
been demonstrated to act directly on the adrenal gland or cultured adrenal chromaffin
cells to stimulate catecholamine secretion. Those substances include histamine,
bradykinin,

angiotensin,

prostaglandins,

and

vasoactive

intestinal

polypeptide

(130,141,153,177). Prolonged incubation of adrenal chromaffin cells with endotoxin in

vitro also enhanced catecholamine release (225). Recent studies have shown that protein
kinase C might be involved in endotoxin effects and activation of protein kinase C is
associated with enhanced catecholamine release from cultured chromaffi.n cells (151,229).

The nature of the involvement of the central nervous system in mediating the
sympathoadrenal activation during endotoxicosis is unknown. Although endotoxin-induced
hypotension may unload the arterial baroreceptors and result in the sympathoadrnal
activation via baroreflex deactivation, numerous studies have shown that the
sympathoadrenal system can still be markedly activated during endotoxicosis in the
absence of hypotension or remain activated after restoration of blood pressure (115,185).
Acidosis with resultant alteration in pH may also increase the sympathetic outflow,
possibly via stimulating the peripheral or central chemoreceptors (50). The activation of
the hypothalamic-pituitary-adrenal axis, which frequently occurs in sepsis, has been
linked to the activation of the sympathoadrenal system (38). Recent studies have
suggested that most endotoxin effects are mediated by releasing cytokines (79). Some of
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the cyktokine effects involve the central nervous system and may be initiated in the brain
(118,194).

Elevation

of

plasma

catecholamines

following

systemic

or

intracerebroventricular administration of tumor necrosis factor or interleukin-! has been
demonstrated (21,202,213,236).
Hemodynamic responses to endotoxin challenge in the present study appeared to
follow the circulating catecholamine levels. Intravenous administration of endotoxin to
pithed rats reduced the arterial blood pressure in a more rapid and severe manner and
without a transient recovery compared with conscious or anesthetized rats receiving
similar dose of endotoxin (114). Such results may be accounted for by the elimination
of centrally-mediated compensatory mechanisms such as the major elevation of plasma
catecholamines as a consequence of pithing. Thus, pithed rats are much susceptible to
endotoxin insult. The late tachycardia in pithed rats was presumably due to the late
increased circulating epinephrine from the adrenal gland. The hypotension and
tachycardia responses following endotoxin in conscious animals were consistent with
many previous results (113,114). The earlier and more profound endotoxin-induced
decreases in MBP in denervated animals compared with sham rats are apparently
attributable to the abolition of neurally mediated early epinephrine response. The
explanation for greater tachycardia response at 60 min post endotoxin in denervated rats
in comparison to that in sham rats is not clear.
Results from the present experiments suggest that plasma norepinephrine response
to endotoxic challenge is solely mediated by central mechanisms whereas epinephrine
response involves both central and peripheral regulations. Centrally-mediated mechanisms
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are dominant and responsible for the major and early elevation of circulating epinephrine.
Peripheral modulation of adrenal epinephrine secretion, most likely non-neurogenic,
contributes to a lesser and prolonged epinephrine response during endotoxicosis.

CHAPTER V

PLASMA CATECHOLAMINE RESPONSE IN SINOAORTIC
DENERVATED RATS FOLLOWING ENDOTOXIN

INTRODUCTION

Hyperactivation of the sympathoadrenal system is generally considered to be one of
the important pathogenic components during the development of septic shock
(157,176,251). The signals responsible for mediating the sympathoadrenal activation
during septic challenge are not clear and are basically unexplored. Since hypotension
typically occurs along with increases in heart rate, sympathetic discharge and plasma
catecholamines during endotoxicosis (93,113,185), it is possible that endotoxin-induced
hypotension may be the primary cause of this activation by deactivating arterial
baroreflexes. It is also important to recognize that in addition to hypotension, decreased
pulsatile pressure without significant changes in mean blood pressure reduces the
baroreceptor activity as well (46,47, 70). A study reported by Chapleau et al. (48) showed
that an endogenous factor derived from activated endothelial cells also diminished the
baroreceptor afferent discharge. These findings may have implications in the sympathetic
activation during sepsis, such that baroreflex deactivation, as a result of decreased
74
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baroreceptor activity, may contribute to the enhanced sympathetic outflow.
A variety of experimental findings have challenged the concept that hypotensioninduced baroreflex deactivation is a dominant factor in mediating sympathoadrenal
response during septic shock. In rats treated with E. coli bacteria, plasma catecholamines
are markedly elevated while blood pressure is not significantly altered (115). In
experiments involving bolus administration of endotoxin to conscious rats, plasma
catecholamines were markedly elevated before hypotension occurred (114). Direct nerve
recording in endotoxic animals indicated that increased sympathetic discharges took place
prior to the onset of hypotension and additional increases in nerve activity occurred
following the fall in blood pressure (185). This activity persisted after blood pressure was
restored to basal levels by volume infusion. Collectively, such evidence suggests that
hypotension does not necessarily initiate or maintain the increased plasma catecholamines
which occur with septic insult.
The aim of the present study was to examine the role of arterial baroreceptors in
mediating sympathoadrenal activation during endotoxicosis by using acutely, as well as
chronically, sinoaortic-baroreceptor-denervated rats. It was hypothesized that baroreflex
deactivation may not be the major factor in mediating the sympathoadrenal activation
during developing endotoxic shock and, thus, the denervation of the arterial baroreceptors
would not eliminate the marked elevation of plasma catecholamines that occurs following
administration of endotoxin. Since endotoxin will initiate dramatic increases in plasma
catecholamines in rats, experiments were designed to treat all animals with endotoxin and
to focus on potential differences between sinoaortic-baroreceptor-denervated and sham-
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treated groups.
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MATERIALS AND METHODS

Experimental Protocols
Three groups of experiments were conducted in male rats weighing 386+ 12 grams.
The first group of experiments were performed in acutely sinoaortic baroreceptor
denervated rats to obtain a preliminary assessment of the baroreceptor role in mediating
the sympathoadrenal activation during endotoxicosis. Bilateral sinoaortic denervation
(SAD, n=6) or sham operation (SHAM, n=6) was performed under xylazin (10 mg/kg,
i.p.) and a-chloralose (70 mg/kg, i.p.) anesthesia as described below. Femoral arterial
and venous cannulae were implanted, and baroreceptor reflexes were tested to confirm
the completeness of SAD. After approximately 1.5 hours equilibration, endotoxin (5
mg/kg) was injected intravenously. MBP and HR were recorded continuously, and
arterial blood samples were collected at 0, 30, 60, and 90 minutes after endotoxin
administration.
The second group of experiments were performed in chronically sinoaortic
baroreceptor denervated rats. This design was employed to prevent possible misleading
results as a consequence of anesthesia and acute surgery. SAD and sham operation were
performed as in acute preparations, and both groups of animals received 40,000 U
penicillin (i.m.) following the surgery. After a 2-4 week recovery period, all rats
underwent surgical implantation of femoral arterial and venous cannulae under halothane
anesthesia (2.0% in oxygen). On the following day, baroreflexes were tested to confirm
the SAD as described before. Endotoxin (5 mg/kg) was then given intravenously to both
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SAD {n=4) and sham (n=5) rats. MBP and HR were recorded continuously, and blood
samples were taken at 0, 30, 60, and 90 minutes after endotoxin administration. Separate
groups of SAD (n=4) and sham animals {n=5) were given saline in place of endotoxin
and were followed during the course of above protocol with subsequent sample collection
and analysis.
The third group of experiments were designed to assess the singular contribution of
hypotension-induced baroreceptor reflexes to the sympathetic activation in the absence
of endotoxin treatment. The cardiovascular and sympathoadrenal responses of rats with
either SAD (n=5) or sham operation (n=5) to hypotension induced by hydralazine, a
vasodilator, were determined. The animals were prepared as in the second group of
experiments, and on the day of the experiment, the baroreceptor reflex testing confirmed
the completeness of the denervation. Hydralazine (1 mg/kg) was given intravenously as
a bolus injection, and MBP and HR were monitored continuously and blood samples
were taken at 0, 15, and 30 minutes.

Sinoaortic Baroreceptor Denervation
Sinoaortic baroreceptor denervation (SAD) was performed as described in chapter
ill. For aortic baroreceptor denervation, the superior laryngeal nerves, the aortic

depressor nerves, and the superior cervical ganglia including a small segment of
sympathetic chain were sectioned. For carotid sinus denervation, all connective tissue and
nerve fibers were stripped from the thyroid, occipital, internal, external and common
carotid arteries. Sham operation was performed by exposing the carotid sinuses bilaterally

79
without dissection of the region. Completeness of baroreceptor denervation was verified
by determining the reflex changes in heart rate following pharmacological alterations in
blood pressure. See general methods for details.

Blood Sample Collection and Catecholamine Assay
Arterial blood samples (500 µl) were collected at pre-determined times and treated
as described in chapter m. Plasma levels of norepinephrine (NE) and epinephrine (BPI)
were assayed in duplicate 50 µ1 samples using the radio-enzymatic thin-layer
chromatographic procedure described in general methods.

Materials
Endotoxin (derived from~ enteritidis) was prepared fresh daily in 0.9% saline (3
mg/ml). Hydralazine was obtained in 20 mg/ml vial and diluted with saline to 1 mg/ml
for i. v. injection. Materials for catecholamine assays were obtained in kit form from
Amersham (Arlington Heights, IL).

Data analysis
Data are expressed as Mean+SEM (n). A p value less than 0.05 was considered to
be statistically significant. Cardiovascular responses and plasma catecholamines following
endotoxin or hydralazine were compared using analysis of variance with repeated
measurements and student-Newman-Keul's test for individual comparisons. Blood
pressure and associated heart rate response to phenylephrine or nitroglycerine infusion
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to assess baroreceptor denervation were compared between the SAD and sham groups

with unpaired student t tests.
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RESULTS

Effects of SAD on Baroreflex Control of Heart Rate
Effectiveness of the baroreceptor reflex was tested in all denervated and sham
animals. Pharmacologic-induced changes in blood pressure were very transient lasting
only a few minutes. As presented in figure 5-1, the increase in MBP induced by
phenylephrine was not different between sham and SAD rats in either acute or chronic
preparations although the chronic animals appeared to have a greater increase than the
acute preparations. Nitroglycerine also caused a similar fall in MBP in acutely prepared
SAD and sham animals, whereas it induced a slightly greater drop of MBP in chronic
SAD compared to sham rats. Both acute and chronic SAD eliminated the bradycardia
caused by the phenylephrine-induced hypertension and the tachycardia associated with
the nitroglycerine-induced hypotension. In contrast, phenylephrine and nitroglycerine
infusion evoked significant bradycardia and tachycardia, respectively, in sham-treated
animals. Low control values of plasma catecholamines prior to the administration of
endotoxin to either SAD or sham group suggest that there were no prolonged effects of
the transient manipulation of blood pressure to test baroreceptor reflexes.

Effects of Acute SAD on Hemodynamic and Sympathoadrenal Activation during
Endotoxicosis
The repeated measures ANOV A showed that the pattern of blood pressure responses
at various times following endotoxin was the same in SAD and sham animals. Within
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each group (i.e. SAD or sham) there were no differences in MBP at 0, 30, 60 and 90
minutes post endotoxin (figure 5-2). However, there was a significant overall difference
(regardless of time) in blood pressures between the SAD and the sham groups following
endotoxin administration. This difference can be seen in figure 5-2, where MBP was
always lower in the sham group compared to the SAD group. HR was significantly
increased (above baseline values) in SAD animals at 30, 60 and 90 minutes post
endotoxin, whereas in the sham group, HR was significantly greater at 60 and 90 minutes
compared to both 0 and 30 minutes.
As shown in figure 5-3, the pattern of plasma catecholamine response following
endotoxin exposure was similar in SAD versus sham animals. In both groups, plasma NE
and BPI become significantly elevated at 30, 60 and 90 min following endotoxin (figure
5-3).

Effects of Chronic SAD on Hemodynamic and Sympathoadrenal Activation during
Endotoxicosis
The pattern of blood pressure responses to endotoxin treatment was not altered by
chronic SAD compared to sham group (figure 5-4). Endotoxin treatment did not induce
significant hypotension in either group. Pre-endotoxin HR was higher in SAD rats
compared with sham rats. There was also a gradual increase in HR with time following
endotoxin administration in the sham group but not in the SAD group (figure 5-4).
As indicated in figure 5-5, the SAD and sham groups had a similar pattern of
plasma NE elevation in response to endotoxin. Although it appeared that SAD animals
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had higher plasma BPI than sham animals at 30 min, lack of statistical difference in the
between the two groups. Following endotoxin treatment, there were marked elevation
plasma catecholamines in both SAD and sham groups over time, i.e. plasma NE and BPI
at 30, 60 and 90 minutes post endotoxin were significantly increased compared to
baseline values (figure 5-5). Saline-treated SAD and sham rats (as controls) showed no
alterations in blood pressure, heart rate or plasma catecholamines during the experimental
protocol.

Effects of SAD on Hemodynamic and Sympathoadrenal Response to Hydralazine
To test the degree of hypotension-induced sympathoadrenal activation with and
without baroreceptor denervation in the absence of endotoxin, measurements of
hemodynamic and plasma catecholamines were made following intravenous administration
of hydralazine (1 mg/kg). This treatment caused a rapid and persistent reduction in mean
blood pressure of both SAD and sham groups over 30 minutes (figure 5-6). However,
the decrease in blood pressure was greater in the SAD compared to the sham group at
5, 10, 15 and 20 minutes post injection, with a peak fall to 63+4 mmHg in the SAD and
78 +3 mmHg in the sham animals. This more profound hypotension in the SAD group
is most likely due to the absence of baroreflex compensation for the blood pressure fall.
The decreases in blood pressure were associated with increases in heart rate in both
groups over time (figure 5-6). Although the sham group exhibited sustained tachycardia
while the SAD animals showed variable changes in heart rate post hydralazine, the
ANOVA statistic showed no significant difference between their patterns, likely due to
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the relatively high total variance. SAD treatment did alter the response pattern of plasma
catecholamines to hydralazine compared to the sham.
As shown in figure 5-7, plasma NE and EPI of the sham group were markedly
elevated at 15 and 30 minutes following hydralazine-induced hypotension, whereas in the
SAD group, plasma NE and EPI were not significantly elevated in response to a greater

drop in blood pressure. This indicates that SAD treatment greatly reduced the
hypotension-induced baroreflex-mediated sympathoadrenal activation. Furthermore, the
increases in plasma catecholamines of the SAD rats were significantly less than that of
the sham group at 15 and 30 minutes post injection (figure 5-7).
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DISCUSSION

The mechanisms responsible for mediating the sympathoadrenal activation during
endotoxicosis are not clear. It is expected that a decrease in systemic blood pressure
induced by endotoxin would unload the arterial baroreceptors and reflexly enhance
sympathetic outflow. Previous studies by Halinen et al. (92,93) demonstrated that
endotoxin administration induced a drop of blood pressure in anesthetized dogs and cats,
which was associated with cessation of the aortic arch baroreceptor afferent impulses and
increased cardiac sympathetic efferent nerve discharges during their 15 minute protocol.
The authors concluded that the sympathetic pathways were primarily activated through
cardiovascular receptor reflexes to maintain blood pressure. However, they did not report
what happened later than 15 minutes. Furthermore, their findings did not necessarily
demonstrate baroreflex mechanism as an exclusive mechanism for sympathoadrenal
activation during endotoxicosis or rule out the possibility of other parallel mechanisms
for initiating the increased central sympathetic outflow.
The experimental data presented here show that SAD treatment did not significantly
alter the response pattern of plasma catecholamines to endotoxin when compared to
sham-operated controls. Although in both figure 5-3 and 5-5 it would appear that
endotoxin induced plasma epinephrine elevations were greater at early stage in denervated
rats compared to sham rats, the change was in a direction opposite from that anticipated
if baroreceptors primarily mediate the sympathetic response. It is also important to
recognize that the hemodynamic and sympathetic alterations observed in the present study

93
are due to the effects of endotoxin and not to the pressure-monitoring or blood sampling
procedures since saline treatment in SAD and sham rats failed to induce changes in these
variables. Collectively, these results suggest that arterial baroreceptor disinhibition is not
the major factor stimulating the sympathoadrenal response to endotoxicosis and suggests
that non-baroreflex mechanisms may be involved. The profound sympathetic activation
occurring in the absence of hypotension further supports that hypotension-induced
baroreflex disinhibition is not essential for sympathoadrenal responses during
endotoxicosis.
Although previous studies in conscious rats with intact baroreceptors reported that
endotoxin-induced sympathetic activation occurred in the presence of hypotension (113),
sympathetic changes were observed in the absence of significant hypotension in the
present study. This discrepancy may be attributable to the fact that the animal
preparations were apparently different between the two studies. The chronic recovery (24 weeks) from a surgery in the present study may somehow altered the blood pressure
response as compared to acute preparations. The lack of hypotension, however, does not
limit the examination of the proposed hypothesis since the pattern and magnitude of
plasma catecholamine response to endotoxin in sham rats were comparable to those
observed in previous study where hypotension existed (196). Furthermore, decreases in
barorceptor afferent nerve activity and associated baroreflex deactivation can be induced
by factors other than hypotension, such as decreases in pulsatile pressure or endothelial
factors (46,47,70). Although a significant hypotension in the present protocol may
presumably lead to an even greater elevation in plasma catecholamines, it is also possible

94
that severe hypotension may result in diminished central nervous system function and
impaired sympathetic outflow.
Administration of bacterial endotoxin to anesthetized dogs subjected to SAD have
also been reported by Koyoma et al. (129). Their results showed that endotoxin
administration induced a fall in both blood pressure and cardiac output with a resultant
increase in total peripheral resistance in both SAD and sham-operated animals. Such
increases in total peripheral resistance reflect increased peripheral sympathetic activity
to peripheral resistance vessels along with decreased cardiac output. In this sense, the
present results are consistent with their findings. Studies by Mills (159) demonstrated that
increased sympathetic discharge occurred before endotoxin-induced hypotension in rats,
indicating that the initiation of sympathetic activation is independent of the baroreflex.
Following the fall of blood pressure, sympathetic nerve activity increased further and was
maintained even after blood pressure was restored to basal levels, suggesting that
maintenance of sympathoadrenal activation is also independent of the baroreflex. Palsson
et al. (185) observed somewhat similar findings with bolus injection of endotoxin in
conscious rats in which endotoxin induced a markedly increased renal sympathetic nerve
activity, that was not diminished after correcting hypotension.
Additional findings of the present study demonstrate the effectiveness of SAD
treatment to alter the response pattern of plasma catecholamines to hydralazine-induced
hypotension. Plasma catecholamines were significantly increased following hydralazine
in the sham controls but not in the SAD rats during the 30 minute protocol. Thus, SAD
appears to be an appropriate model to eliminate or significantly blunt the baroreceptor-
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induced sympathoadrenal activation and to test whether such activation occurs during
endotoxicosis. The increments of plasma catecholamines induced by hydralazine-evoked
hypotension were far less than that induced by endotoxin administration. Such results
further suggest that mechanisms other than hypotension-induced baroreflex activation are
involved in the sympathoadrenal response to endotoxin.
In both acute and chronic preparations, SAD animals had higher baseline blood
pressure compared to sham animals. Such relative hypertension is in agreement with most
of the previous reports (169,239) and may be attributable to the elimination of afferent
input to the central nervous system, which normally inhibits sympathetic pathways. Thus,
sinoaortic denervation results in higher basal central sympathetic outflow. In acute
preparations blood pressures in the sham group were always lower compared to that in
the SAD group post endotoxin. In an isolated carotid sinus model, Trank and Visscher
(238) found that the relationship of baroreceptor discharge frequency versus intrasinus
pressure was shifted to the left during endotoxicosis. Baroreceptor-nerve activity was
always higher for a given pressure stimulus, which led to a reflex inhibition of
sympathetic outflow. By denervating arterial baroreceptors, this baroreceptor resetting
might be eliminated, which could account for the sympathetic outflow being higher in
SAD rats than in baroreflex intact rats. However, this explanation is unlikely to account
for the difference in blood pressure following endotoxin between the SAD and sham
groups, since this difference was not seen in chronic preparations. The most plausible
factors responsible for the difference between acute and chronic preparations may be cxchloralose anesthesia and the acute effect of SAD. Alpha-chloralose anesthesia has been
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reported to possibly augment baroreceptor reflexes to maintain normal blood pressure
(39). Acute SAD eliminates the inhibitory baroreflex and results in relative hypertension.
In the literature conflicting results concerning the HR changes following endotoxin
have been reported (115,128,137). Both tachycardiac and bradycardic reactions have been
observed. These different results might be due to differences in animal spices, anesthesia,
basal HR, and reactive states of the baroreceptor reflex. In the present study HR changes
induced by endotoxin are not uniform from one preparation to another. In acute
experiments HR of sham animals was not significantly elevated until 60 and 90 minutes
post endotoxin, whereas the HR of SAD animals continuously increased with time
following endotoxin. In chronic experiments, HR was increased with time post endotoxin
in both sham and SAD animals, but only reached statistical significance in the sham
group. Since endotoxin-treated SAD rats had higher basal HR compared to sham rats,
the presence of tachycardia in SAD rats may make a further acceleration undramatic.
Hydralazine-induced hypotension evoked a sustained tachycardia in sham animals,
whereas SAD rats exhibited variable changes in HR.
In conclusion, the data from the present study suggest that the afferent input from
the arterial baroreceptors is not the major factor, or not even essential, in mediating
sympathoadrenal activation during endotoxicosis. Non-baroreflexogenic mechanisms may
be involved in stimulating such activation.

CHAPTER VI

RENAL SYMPATHETIC RESPONSE IN SINOAORTIC
DENERVATED, CONSCIOUS RATS FOLLOWING ENDOTOXIN

INTRODUCTION

Endotoxin-induced hypotension and associated baroreceptor reflexes have been
suggested to be the primary cause of the sympathoadrenal activation during endotoxicosis
(92,93,148).

However,

accumulating

experimental

findings

suggest

that

the

sympathoadrenal system can be markedly activated by endotoxin or bacteria in the
absence of significant hypotension (89, 115) and remains activated after restoration of
blood pressure with volume infusion (159). Results from previous chapter further
demonstrated that in sinoaortic baroreceptor denervated rats bacterial endotoxin
administration elevated plasma catecholamines to a similar, if not higher, level compared
to sham-operated animals (255). These results suggest that the afferent input from the
arterial baroreceptors is not essential in elevating plasma catecholamines with
endotoxicosis. Although no hypotension was observed in those animals following
endotoxin, decreased baroreceptor activity and resultant baroreflex deactivation can be
evoked by factors other than hypotension (see Chapter V for details).
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Plasma catecholamines, released from the peripheral sympathetic nerve terminals
and the adrenal medulla, have been widely used as an index of sympathoadrenal activity.
However, circulating catecholamine levels can be influenced not only by their release but
also by neuronal uptake and peripheral catabolism (84), such that increases in plasma
catecholamines may occur without alterations in catecholamine release (152). Therefore,
plasma catecholamines may not adequately quantitate sympathetic activity as compared
to direct nerve recording. Despite the frequent demonstration of an elevation of plasma
catecholamines during clinical or experimental sepsis, contradictory results have been
reported with direct measurements of sympathetic nerve activity, i.e. direct nerve
recordings (127,128,159,185). In addition, differential sympathetic responses have been
observed during shock states (232,242), such that the sympathetic outflow is increased
to one organ while decreased to another. Thus, although plasma catecholamines and
sympathetic discharge both represent the functional state of the sympathoadrenal system,
they may not always change in a parallel manner.
Considering these factors as well as the fact that plasma catecholamines and
sympathetic discharge have never been simultaneously determined in septic animals, the
present study was conducted. Both plasma catecholamine measurements and renal
sympathetic recording techniques were employed to assess the contributions of afferent
neural input from arterial baroreceptors to sympathoadrenal responses in conscious,
unstrained endotoxic rats. Endotoxin was used as a septic agent based on the large body
of literature showing that endotoxin administration· to experimental animals duplicates
many pathophysiological changes observed in patients with sepsis or septic shock
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(104,122,168,171). To accomplish our objective, conscious rats with either sinoaortic
denervation (SAD) or intact baroreceptors were subjected to intravenous endotoxin
treatment. Renal sympathetic nerve activity (RSNA) and circulating catecholamines were
monitored both before and following the injection of endotoxin. It was hypothesized that
removal of baroreceptor afferent input would not eliminate the endotoxin-evoked
peripheral sympathoadrenal activation, as reflected in both the renal sympathetic nerve
activity and plasma catecholamines.
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MATERIALS AND METHODS

Experimental Protocols
Holzman Rats, weighing 396+ 12 grams, were anesthetized with sodium
pentobarbital (60 mg/Kg, i.p.). Sinoaortic baroreceptor denervation and sham operation
were performed as described in chapter III. Each animal received 40,000 U penicillin
(i.m.) following the surgery. After a 2-4 week recovery period, all rats underwent
surgical implantation of arterial and venous cannulae as well as electrode placement for
recording renal sympathetic nerve activity under pentobarbital anesthesia (60 mg/kg,
i.p.). After a 24 hr recovery, cannulae and electrodes were extended to instruments to
record blood pressure and renal sympathetic nerve activity (RSNA). Following a 0.5 hr
equilibration period, baroreflexes were tested to confirm the SAD. Endotoxin (5 mg/Kg)
was then given intravenously to both SAD (n =6) and sham animals (n =7). Separate
groups of SAD (n=4) and sham {n=5) rats also received equivalent amount of saline for
time-matched control. Mean blood pressure (MBP), heart rate (HR), and RSNA were
determined at 0, 5, 15, 30, 60, and 120 min after infusions. Blood samples were taken
at 0, 15, 90, and 180 min post treatments.

Sinoaortic Baroreceptor Denervation
Sinoaortic baroreceptor denervation (SAD) was performed by a method as described
in chapter III. Briefly, for aortic baroreceptor denervation, the superior laryngeal nerves,
the superior cervical ganglia including a small segment of sympathetic chain and the
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aortic depressor nerves were sectioned. For carotid sinus denervation, all connective
tissue and nerve fibers were stripped from the thyroid, occipital, internal, external and
common carotid arteries. Sham operation was performed by exposing the carotid sinuses
bilaterally without dissection of the region. Completeness of baroreceptor denervation
was tested as described before.

Sympathetic Nerve Recording
Renal sympathetic nerve activity (RSNA) was recorded from a renal nerve branch
of the left greater splanchnic nerve. Briefly, the left kidney was exposed retroperitonealy,
and the renal nerve branch was found in the aortic-renal artery angle. After the renal
nerve branch was dissected free the nerve was carefully placed on a thin, bipolar gold
electrode. When an optimal nerve signal was obtained, the electrode and the nerve was
fixed with a rubber gel mixture. The electrode wires were exteriorized on the back of the
neck. On the next day, the electrode wires were extended to the amplifier. The nerve
signal was amplified 1,000-10,000 fold and filtered (low-frequency cutoff at 35 Hz and
high-frequency cutoff at 2,000 Hz). Then the amplified signal was full-wave rectified and
integrated by two separate models of integrator for simultaneous estimation of
frequencies of RSNA (measured as spikes/min) and overall RSNA (measured as slopes).
The rectified signal was continuously recorded on a Grass oscillograph. The background
noise level for the nerve recording was determined 30 min after each animal was killed
with pentobarbital overdose. All RSNA were expressed as percent of baseline control.
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Blood Sample Collection and Catecholamine Assay
Arterial blood samples (500 µL) were collected at different time points as described
above and assayed for plasma catecholamines using the radio-enzymatic thin-layer
chromatographic procedure described in general methods.

Materials
Endotoxin (derived from

S.. enteritidis) was prepared freshly in 0.9% saline (3

mg/ml). Materials for catecholamine assay were obtained in kit form from Amersham
(Arlington Heights, IL). Phenylephrine, nitroglycerine and penicillin were purchased
from Sigma, St. Louis, MO, Baxter, McGaw Park, IL and Pfizer, New York, NY,
respectively.

Data Analysis
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to
be statistically significant. Cardiovascular responses, RSNA, and plasma catecholamines
were compared using analysis of variance with repeated measurements and StudentNewman-Keul's test for individual comparison. Blood pressure and associated heart rate,
RSNA responses to phenylephrine or nitroglycerine infusion were compared between the

SAD and Sham groups with an unpaired Student t test.
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RESULTS

Effects of SAD on Baroreflex Control of HR and RSNA:
Effectiveness of the baroreceptor reflex was tested in all animals. The
pharmacologic-evoked changes in blood pressure were very transient, lasting only a few
minutes. Phenylephrine administration induced an identical rise and nitroglycerine caused
a similar fall of MBP in SAD rats compared to the sham group. The phenylephrineinduced hypertension was associated with profound bradycardia and inhibition of RSNA,
and nitroglycerine induced-hypotension evoked significant tachycardia and excitation of
RSNA in sham-treated animals (figure 6-1 and 6-3). In contrast, SAD eliminated or
significantly attenuated reflex changes of HR and RSNA in response to those
pharmacological alterations in blood pressure (figure 6-2 and 6-3).

Hemodynamic Responses to Endotoxin Infusion:
The baseline MBP was not different among all animals. SAD and sham rats had
similar patterns of blood pressure response after endotoxin administration with no
significant alterations in MBP from control values (figure 6-4). There were also no
significant differences in baseline HR between SAD and sham animals. Endotoxin
induced a modest, but not significant, increase in HR in the sham group during the
experiment. In contrast, SAD rats showed significant tachycardia at 5 min after endotoxin
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Figure 6-1. Baroreflex test from a conscious sham-operated rat showing blood pressure
(BP), heart rate (HR), renal sympathetic nerve activity (RSNA) spike and slope responses
to intravenous phenylephrine (A) and nitroglycerine (B).
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infusion which was maintained for the duration of the protocol. In saline-treated SAD and
sham rats, there was no alterations in MBP or HR over the course of the experiment.

Sympathetic Responses to Endotoxin Infusion:
Endotoxin administration induced very rapid and sustained increases in both RSNA
and plasma catecholamines. For both SAD and sham groups, RSNA was markedly
increased as early as 5 min after endotoxin infusion with the peak increase occurring
between 15-30 min post endotoxin which remained elevated during the protocol (figure
6-5 and 6-6). RSNA spikes and slopes basically changed in a parallel manner, although
the magnitudes are not identical. Interestingly, RSNA response at 5 and 15 min post
endotoxin was 2 fold higher in SAD rats compared to sham rats. Rapid and significant
elevations in plasma norepinephrine (NE) and epinephrine (BPI) were also apparent at
15, 90, and 180 min after endotoxin administration in both SAD and sham groups
compared to baseline values (figure 6-7). Similar to the RSNA response, plasma NE and
BPI levels at 15 min post endotoxin were also significantly higher in SAD group
compared to the sham group. Saline-treated SAD and sham rats showed no alterations
in RSNA and plasma catecholamines during the experimental protocol.
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Figure 6-6. Percent changes of renal sympathetic nerve activity (RSNA) spikes and
slopes in conscious rats with sinoaortic denervation (SAD) or sham
operation (SHAM) following intravenous endotoxin (ETX, 5 mg/kg) or saline. *:
p<0.05 for SAD post endotoxin vs. 0 min; #: p<0.05 for SHAM post endotoxin vs.
0 min; +: p<0.05 for endotoxin-treated SAD vs. SHAM.
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DISCUSSION

The principal findings of the present study demonstrate a marked elevation in
sympathoadrenal activity following endotoxin in conscious rats, as indicated by parallel,
but not identical, changes of direct renal sympathetic nerve recording and plasma
catecholamine measurements. Such rapid onset and apparently simultaneous increases
have not been previously reported, and the elevations are of a profound magnitude lasting
for several hours. Furthermore, since these increments occurred in both sham and SAD
rats, it suggests that the arterial baroreflex is not essential in mediating such activation.
The baroreflex control is intact in sham operated rats, as determined by reflex
bradycardia and sympathoinhibition as well as reflex tachycardia and sympathoexcitation
in response to pharmacologically induced alterations in blood pressure. With intact
arterial baroreceptor control of the circulation, intravenous endotoxin administration
induced rapid and significant increases in both renal sympathetic activity and plasma
catecholamines. These results further corroborate and also extend previous findings which
demonstrated significant elevation of plasma catecholamines in different septic models
of various animal species and septic patients (17,75,113,115,218). The markedly
increased RSNA in the present study also agrees with the reports from the literature
showing augmented sympathetic discharge following septic insult in different species
(93,159,185). Although Koyama et al. reported that efferent sympathetic nerve activity
in rabbits and cats was decreased following sepsis (127,128), the differences in species
and the use of anesthesia may account for these observations.
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In SAD rats, both major arterial baroreceptors, i.e. carotid sinus and aortic arch
baroreceptors are deafferented. The effectiveness of this treatment is indicated by the
failure of reflex changes of HR in response to arterial pressure change induced by
pharmacological agents. Such observations are routinely used as the criteria of the
completeness of the SAD (8,13,15,169). Direct recording of reflex changes of renal
sympathetic activity also suggests that baroreflex control of the circulation is greatly
blunted in SAD compared to intact animals. The significant attenuation in reflex RSNA
changes in SAD group corresponds to the same directional change of HR. However, the
degree of attenuation of RSNA changes with vasoconstrictor and vasodilator agents is less
than that of corespondent HR changes. This observation raises the possibility that the
cardiomotor component of arterial baroreflex is completely abolished by SAD while the
vasomotor component of the reflex is not (90). Several lines of evidence suggest that this
is unlikely. First, we have shown that the same SAD preparation in our laboratory
significantly abolished reflex elevation of plasma catecholamines in response to
hydralazine-induced hypotension compared to intact control rats (255), suggesting that
overall baroreflex-mediated sympathoadrenal activation is disrupted by SAD. Second, we
and other investigators have observed that SAD markedly potentiates the fall in arterial
pressure with hydralazine (224,255), indicating that the vasomotor component of
baroreflexes is also significantly reduced. Third, SAD has been shown to be able to
eliminate both the cardiomotor and sympathetically-mediated vasomotor components of
the baroreflex in a parallel manner (90). Taken together, SAD is capable of eliminating
or significantly blunting the baroreflex-mediated sympathoadrenal activation. The
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remaining changes of RSNA with arterial pressure alterations may be explained by the
observation that there is still a selective renal sympathetic activation to pressure changes
after the baroreflex arc is destroyed. Hubbard et al. (108) reported that plasma renin and
plasma NE were elevated by hydralazine-induced severe hypotension in rats with nucleus
tractus solitarii lesion {NTS). These elevations were completely abolished by bilateral
renal denervation, indicating a selective renal sympathetic activation which is controlled
by an area lying outside of the NTS, independent of baroreflex arc. Another possibility
is that cardiopulmonary receptor reflex may mediate the RSNA changes (232). These
receptors are primarily innervated by vagal nerves and not disrupted by SAD.
Furthermore, these receptors can differentially regulate sympathetic responses, e.g.
RSNA versus adrenal sympathetic nerve activity (232).
After disruption of arterial baroreflex control with SAD, RSNA as well as plasma
catecholamines were still rapidly and markedly elevated by endotoxin. This result implies
that the baroreflex does not play a major role in turning on as well as maintaining
sympathoadrenal

activation

with

endotoxin

administration.

The

significant

sympathoadrenal activation in association with the absence of hypotension following
endotoxin in both sham and SAD animals in the present study further supports this
concept. The explanation for the absence of hypotension following endotoxin in the
present study may again involve chronic recovery (2-4 weeks) from a major surgery,
which somehow altered the blood pressure response as compared to acute preparations.
Interestingly and surprisingly, the sympathetic responses to endotoxin were more
profound in the early phase in SAD animals compared to sham-operated controls. This
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heightened response was also accompanied by a greater increase in HR in the SAD group
versus sham rats. Results from Barron and Heesch (15) may provide a possible
explanation for the present findings. They demonstrated that baroreceptor denervation
potentiates the cardiovascular effects and sympathetic outflow elicited by the central
nervous

system

activation

such

as

posterior

hypothalamic

stimulation

and

intracerebroventricular injection of angiotensin II. They proposed that arterial
baroreceptor reflexes exert an effective buffering of pressor stimuli initiated from the
central nervous system and that elimination of this buffering mechanism with SAD would
augment the centrally-mediated cardiovascular and sympathetic responses. It is important
to recognize that the profound sympathoadrenal responses to endotoxin involve intact
central nervous system (112) and such responses tend to elevate BP. Analogous to Barron
and Heesch's finding, this endotoxin-induced, centrally-mediated pressor stimuli also can
not be buffered in SAD animals, since this modulating mechanism is interrupted with
SAD. As a consequence, higher RSNA and plasma catecholamine following endotoxin
are seen in the SAD group.
The mechanisms responsible for mediating sympathoadrenal activation during
endotoxicosis can not be determined in the present experiment. Such rapid and profound
activation may suggest a direct action of circulating mediators on the central nervous
system during endotoxicosis. Alternatively, rapid peripherally-elicited, centrally-mediated
reflex mechanisms might be involved. Although local modulation of catecholamine
release from the adrenal gland has been suggested in endotoxic animals (112,211), more
studies are needed to determine its importance. It is concluded from the present study,
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that the sympathoadrenal response to endotoxin infusion is a very rapidly-occurring and
long-lasting event and that afferent neural input from arterial baroreceptors is not
essential in mediating such activation during developing septic shock. The elimination of
feedback buffering mechanisms with SAD may account for the augmented sympathetic
response seen in SAD animals. More studies need to be done to elucidate the mechanisms
responsible for this activation.

CHAPTER VII

SYMPATHOADRENAL RESPONSES TO CENTRAL ADMINISTRATION
OF ENDOTOXIN, INTERLEUKIN-1

/3, INTERLEUKIN-6, AND

TUMOR NECROSIS FACTOR ex IN CONSCIOUS RAT

INTRODUCTION

Systemic administration of bacterial endotoxin, as a model of septic insult, results
in the profound sympathoadrenal activation, as indicated by the direct sympathetic nerve
recording and plasma catecholamine measurements (93, 113,185). Endotoxin effects are
recognized to be mediated primarly by the release of cytokines, a family of protein
molecules produced by macrophages and other cells. Interleukin-1 (IL-1), tumor necrosis
factor ex (TNF ex), and interleukin-6 (IL-6) have been extensively studied and shown in
particular to be linked to the pathogenesis of the septic syndrome (37,79). Among the
multifunctional actions of these cytokines are actions on the central nervous system, some
of which may be initiated on the brain side of the blood brain barrier. The central effects
include induction of fever, activation of the hypothalamic-pituitary-adrenal axis,
suppression of food intake, slow wave sleep, and acute phase response (66,118,194,214).
The brain site of cytokine actions has been proposed in the hypothalamus (69,194). Brain
117
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tissues

have receptors

for,

and can respond

direct! y to certain cytokines

(107,117,194,250). Furthermore, IL-1 immunoreactive innervation has been shown to
exist in various brain areas including the hypothalamus (34,136), and also some brain
cells can produce IL-1, TNF and IL-6 in response to endotoxin or inflammatory
challenge either in vitro or in vivo (82,95, 135,138,200).
Thus, cytokines might be plausible factors in mediating the sympathoadrenal
activation with systemic endotoxin via their central actions. To test this hypothesis,
endotoxin, IL-1, TNF or IL-6 was administered into the lateral ventricle of conscious
rats, and renal sympathetic nerve activity (RSNA) as well as plasma catecholamine
responses were assessed. Among the potential brain sites of cytokine effects on the
sympathetic nervous system, the paraventricular nucleus of the hypothalamus (PVN) is
a likely candidate. First, the PVN has extensive projections to sympathetic neurons in the
spinal cord (56) and electrical and chemical stimulations of the PVN increase sympathetic
outflow and plasma catecholamines (226). Second, electrical activity of neurons in the
PVN is altered during immune responses (23,205) and the PVN may be involved as an
IL-1 action site for induction of corticotropin releasing factor (CRF) and pituitary-adrenal
axis activation (203). Third, IL-1 immunoreactive innervation to the PVN has been
demonstrated (34,136). Thus, to test whether the PVN is a site of cytokine actions in
mediating sympathoadrenal response, each of the cytokines was administered to the PVN,
and sympathetic responses were determined.
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MATERIALS AND METHODS

Experimental Protocols
Holtzman rats, weighing 396+ 12 grams, were used in this study. Under
pentobarbital anesthesia (60 mg/kg, i.p.), a carotid artery and a jugular vein were
cannulated with polyethylene tubing. Bipolar, gold electrodes were then implanted on one
renal branch of the left greater splanchnic nerve for recording renal sympathetic nerve
activity (RSNA). The ends of cannulae and electrode wires were exteriorized on the back
of the neck. A final procedure under the anesthesia was to insert a stainless steel cannula
into the lateral ventricle through the skull or a bilateral cannula to both sides of PYN.
After a 24 hr recovery, cannulae and electrodes were extended to instruments to record
blood pressure and RSNA. Following a 0.5 hr equilibration period, endotoxin (ETX,
1000 ng, n=6), IL-1 {3 (100 ng, n=5, 1000 ng, n=5), IL-6 (100 ng, n=5, 1000 ng,
n=5), TNF a (100 ng, n=5, 1000 ng, n=5), or saline vehicle (n=5), all in 10 µl
volume, was administered ICY using a Hamilton syringe. For PYN injection, IL-1 {3
(1000 ng, n=7), IL-6 (1000 ng, n=5), TNF a (1000 ng, n=6), or saline vehicle (n=5),

all in 0.5 µl volume, was delivered bilaterally to the PYN. Those doses were chosen
mostly based on the doses used in previous studies reported in the literature
(194,202,213). Hemodynamic responses, RSNA and plasma catecholamines were
assessed at 0, 30, 60, 90, and 180 min post injection. The localizations of the tips of the
ICY and PVN cannulae were histologically determined at the termination of the
experiments.
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In addition, a control group (n =4) was setup to demonstrate a positive sympathetic

response with PVN injection of a synthetic opioid peptide [D-Ala2 ,NMe-Phe4 , Glyol5]enkephalin (DAGO). DAGO, when injected into the PVN, induces catecholamine
secretion through activation of the central sympathetic outflow to the adrenal medulla and
sympathetic nerve terminals. Bilateral PVN administration of DAGO (10 µg in 500 nl
volume) caused significant elevations of RSNA spikes (25+8% at 5 min, 38+ 11 % at 15
min) and slopes (45+18% at 5 min, 75+5% at 15 min). Saline infusion to the same
group of rats changed neither RSNA spikes (-1 +3% at 5 min, -2+ 1 % at 15 min) nor
slopes (-2+4% at 5 min, -1 +4% at 15 min).

Sympathetic Nerve Recording
Renal sympathetic nerve activity (RSNA) was recorded from a renal nerve branch
of the left greater splanchnic nerve, as described in chapter

m.

After exposing the left

kidney retroperitoneally, the renal nerve branch was separated from fat and connective
tissues. It was carefully placed on a thin, bipolar gold electrode. When an optimal nerve
signal was obtained, the electrode and the nerve was fixed with a gel mixture. The
electrode wires were exteriorized on the back of the neck. On the next day the nerve
signal was amplified, rectified and integrated for estimation of frequencies of RSNA
(measured as spikes/min) as well as overall RSNA (measured as slopes). The integrated
signals were continuously recorded on a Grass oscillograph. The post mortem renal nerve
activity was recorded in all animals as a measure of the background noise level. All
RSNA was expressed as percent change from baseline control.

121
Implantation of Intracerebroventricular (ICV) Cannulae
Under anesthesia, a 30 gauge stainless steel cannula was implanted into the lateral
ventricle with the tip stereotaxic coordinates: 0.5 mm caudal to bregma, 1.5 mm lateral
to the midline, and 4.5 mm below the surface of the skull. The end of the cannula was
pre-bent to a right angle and connected to a piece of PE-10 tubing (5 cm long), filled
with saline (3-4 µl) and heat sealed. On the day of experiment, the cannula was extended
to a 10 µl Hamilton microsyringe filled with test solution. Ten µl test solution (plus 3-4
µl saline in the cannula) was infused over a period of 5 min. The ICV injection was
verified by showing ventricular staining after a dye injection via the canula (examples
shown in figure 7-1).

Implantation of PVN Cannulae
Using a stereotaxic apparatus, a 26 gauge bilateral guide cannula comprised of steel
tubes with a 1.0 mm distance between the centers was implanted to the bilateral PVN.
The coordinates for PVN were 1.7 mm caudal to bregma, 0.5 mm lateral to the
midsagital suture and 8.0 mm ventral to the skull surface. A dummy wire with two leads
was inserted into the guide cannula to prevent clotting and to prevent dust from getting
into the cannula. On the day of experiments, the dummy wire was removed and a double
injector cannula (33 gauge) which was constructed 2 mm longer than the guide cannula
was inserted into the guide cannula. The injector cannula was connected to a 10 µl
Hamilton microsyringe. A testing solution (500 nl) was injected bilaterally over a 5 min
period. The exact injection site was histologically verified in each animal at the end of
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Figure 7-1. Coronal brain sections showing staining of the lateral ventricles after dye
injection via an intracerebroventricular (ICV) cannula.
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experiments. Only those animals with the cannula terminated in the dorsal border of the
PVN without damage of PVN neurons were included in the statistical evaluation
(example shown in figure 7-2).

Blood Sample Collection and Catecholamine Assay
Arterial blood samples (500 µl) were collected at different time points as described
above. Plasma levels of norepinephrine and epinephrine were assayed in duplicate 50 µl
samples using the radio-enzymatic thin-layer chromatographic procedure described
previously.

Materials
For ICV infusion, endotoxin, IL-1, IL-6, and TNF were prepared in phosphatebuffered saline containing 0.2 % bovine serum albumin at a concentration of 10 µg/ml
for the dose of 100 ng/rat and 100 µg/ml for the dose of 1000 ng/rat. For PVN infusion,
IL-1 and TNF were prepared in 0.9 % sodium chloride at concentrations of 0.2 mg/ml
for the dose of 100 ng/rat and 2 mg/ml for the dose of 1000 ng/rat. Saline vehicle
contained equivalent amount of bovine serum albumin. DAGO was purchased from
Peninsula, San Carlos, CA. Materials for catecholamine assay were obtained in a kit
form from Amersham (Arlington Heights, IL).

Data Analysis
Data are expressed as mean+SEM (n). A p value less than 0.05 was considered to
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Figure 7-2. Coronal brain sections at the level of paraventricular nucleus of the
hypothalamus (PVN). The tips of the cannula were shown to terminate at the dorsal
border of the PVN.
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be statistically significant. Cardiovascular responses, RSNA, and plasma catecholamines
were compared using analysis of variance with repeated measurements and StudentNewman-Keul's test for individual comparisons.
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RESULTS

Hemodynamic and Sympathoadrenal Responses to ICV Injection of Endotoxin
As shown in figure 7-3, ICV administration of endotoxin (1000 ng/rat), given over
a 5 min period, did not cause significant changes in arterial mean blood pressure (MBP)
or heart rate (HR) during the 120 min protocol. There were also no significant alterations
in RSNA, both spikes and slopes, over times following endotoxin. Post treatment plasma
norepinephrine (NE) and epinephrine (EPI) remained at the levels similar to the controls.
ICV injection of saline failed to elicit any changes in MBP, HR, RSNA or plasma
catecholamines.

Hemodynamic and Sympathoadrenal Responses to ICV injection of IL-1 {3
As indicated in figure 7-4, neither MBP nor HR was significantly altered by ICV
administration of low and high doses (100 ng, 1000 ng) of IL-1 {3. These two doses of
IL-1 induced basically similar patterns of increases in RSNA, as indicated by both spikes
and slopes. The increments of RSNA were modest, approximately 20-30% of baseline
values. Peak elevations were reached between 30 to 90 min post injection and remained
elevated thereafter. In parallel, ICV IL-1 treatment evoked significant elevations of
plasma catecholamines. Both low dose and high dose of IL-1 elevated plasma NE
throughout the 180 min protocol. At 60 min, the NE elevation induced by high dose was
higher than that induced by low dose whereas at 180 min the opposite was seen. Plasma
EPI was elevated by low dose of IL-1 at 90 and 180 min post injection.
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Figure 7-3. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine
responses to ICV injection of endotoxin (ETX) or saline in conscious rats. MBP: mean
blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity; NE:
norepinephrine; EPI: epinephrine.
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Figure 7-4. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine
responses to ICV injection of low and high doses of IL-1 (3 or saline in conscious rats.
MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity;
NE: norepinephrine; BPI: epinephrine. x: p < 0.05 for both low and high dose groups,
compared with baseline values; # p < 0.05 for low dose group, compared with baseline
values;*: p<0.05 for high dose group, compared with baseline values; +: p<0.05 low
dose group vs. high dose group.
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High dose of IL-1 evoked elevation of plasma BPI at all sampling times during 180 min.
The increments in BPI evoked by low dose of IL-1 were higher than those induced by
high dose.

Hemodynamic and Sympathoadrenal Responses to ICV injection of TNF a
Neither MBP nor HR was altered within 180 min following ICV administration of
TNF (figure 7-5). TNF induced significant decrease in RSNA, as indicated by both
spikes and slopes (approximately 20% ). The pattern of these depressions induced by the
two doses of TNF were similar to each other. The depression in spikes reached
significance at 30, 60, 90, and 180 min while the depression in slopes reached
significance at 60, 90, and 180 min post treatment. Plasma NE or BPI did not change
significantly following ICV injection of TNF.

Hemodynamic and Sympathoadrenal Responses to ICV injection of IL-6
As presented in figure 7-6, ICV injection of IL-6 at doses of 100 ng and 1000 ng
did not alter MBP or HR significantly. The pattern of RSNA responses, both spikes or
slopes, to low dose and high dose of IL-6 were quite different from each other. Low
dose of IL-6 did not change RSNA spikes or slopes at any time post injection whereas
high dose of IL-6 induced significant depression in both spikes and slopes during the 180
min sampling period. The peak depression was approximately 20% for RSNA spikes and

was about 30% for RSNA slopes. Plasma NE or BPI did not change significantly
following IL-6.
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Figure 7-5. Hemodynamic, renal sympathetic nerve activity and plasma
catecholamine responses to ICV injection of low or high doses of TNF a or saline in
conscious rats. MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic
nerve activity; NE: norepinephrine; EPI epinephrine. x: p < 0.05 for both low and high
dose groups, compared with baseline values.
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Figure 7-6. Hemodynamic, renal sympathetic nerve activity and plasma catecholamine
responses to ICV injection of low and high doses of IL-6 or saline in conscious rats.
MBP: mean blood pressure; HR: heart rate; RSNA: renal sympathetic nerve activity;
NE: norepinephrine, EPI: epinephrine. *: p < 0.05 for high dose group, compared with
baseline values; +: p < 0.05 low dose group vs. high dose group.
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Hemodynamic and Sympathoadrenal Responses to PVN Injection of IL-1
As shown in table 7-1, PVN injection of IL-1 induced mild but significant elevation
in mean arterial blood pressure at 60, 90, and 180 min post injection as compared to the
baseline values. Simultaneously heart rate was slightly but not significantly increased.
PVN injection of IL-1 had no marked effects on RSNA, both spikes and slopes (table 72). Plasma NE and EPI were slightly elevated at 90 and 180 min after IL-1 injection
(table 7-3). Plasma NE increased from preinjection value of 331 +45 pg/ml to 520+61
pg/ml at 90 min and 567+ 103 pg/ml at 120 min. Plasma EPI increased from baseline
value of 159+23 pg/ml to 349+64 pg/ml at 90 min and 378+59 pg/ml at 120 min. PVN
injection of saline did not evoke any significant changes in MBP, HR, RSNA, and
plasma catecholamines.

Hemodynamic and Sympathoadrenal Responses to PVN Injection of TNF
There were no significant alterations in blood pressure or heart rate
following PVN injection of TNF (table 7-1). PVN TNF induced slight ( < 10 %) but
significant decreases in RSNA slopes at 60, 90, 120 min post injection without significant
changes in RSNA spikes (table 7-2). PVN TNF had no effects on plasma catecholamines
(table 7-3).

Hemodynamic and Sympathoadrenal Responses to PVN injection of IL-6
As shown in table 7-1, IL-6 injection to PVN induced an increase in HR at 60 min
without significant alteration in blood pressure. RSNA (both spikes and slopes) and
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Table 7-1. Effects of saline vehicle, IL-1 {3, TNF a and IL-6 injections into the
paraventricular nucleus of the hypothalamus (PVN) on mean blood pressure (MBP) and
heart rate (HR). *: p<0.05 post treatment values vs. baseline value.

POST TREATMENT MBP

Time (min)
SALINE

IL-1
(1000 ng)
TNF

(1000 ng)
IL-6

(1000 ng)

0

30

{mmH~;u
60

90

180

101±1
(n=5)

102±1

105±2

105±2

103±2

108±3
(n=7)

112±5

116±4*

118±4*

116±4*

109±3
(n=6)

109±2

110±2

110±2

112±4

111±4
(n=5)

111±4

115±8

117±8

115±7

60

90

180

POST TREATMENT HR (beats7min)

Time (min)
SALINE

IL-1
(1000 ng)
TNF

(1000 ng)
IL-6

(1000 ng)

0

30

398±7
(n=5)

388±22

393±21

394±20

401±21

404±5

411±8

431±10

435±11

436±14

398±8
(n=6)

415±13

400±16

398±19

400±17

420±8

456±21

476±20*

444±22

445±22

(n=7)

(n=5)
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Table 7-2. Effects of saline vehicle, IL-1 (3, TNF a and IL-6 injections into the
paraventricular nucleus of the hypothalamus (PVN) on renal sympathetic nerve activity
(RSNA) spikes and slopes in conscious rats. *: p<0.05 post treatment values vs.
baseline value.

Time (min)
SALINE

CHANGE OF RSNA SPIKES

l'

0

60

90

180

30

control!

100±0
(n=5)

97±5

97±3

99±3

99±4

IL-1
(1000 ng)

100±0
(n=7)

114±9

99±6

95±7

92±5

TNF
(1000 ng)

100±0
(n=6)

98±5

96±4

95±3

90±8

IL-6
(1000 ng)

100±0
93±2
96±3
94±3
(n=5)
CHANGE OF RSNA SLOPES (% control)

100±6

Time (min)

0

30

60

90

180

100±0
(n=5)

99±3

96±2

99±1

99±1

IL-1
(1000 ng)

100±0
(n=7)

114±9

98±8

97±9

94±10

TNF
(1000 ng)

100±0
(n=6)

96±2

93±3*

91±2*

92±3*

IL-6
(1000 ng)

100±0
(n=5)

98±3

97±2

99±4

96±5

SALINE
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Table 7-3. Effects of saline vehicle, IL-1 [j, TNF ex and IL-6 injections into the
paraventricular nucleus of the hypothalamus (PVN) on plasma norepinephrine (NE) and
epinephrine (EPI) in conscious rats. *: p<0.05 post treatment values vs. baseline value.

PLASMA NOREPINEPHRINE i:e2Lm 1 1

Time (min)
SALINE

0

30

60

90

180

406±78
(n=5)

423±21

462±21

443±38

456±42

IL-1
(1000 ng)

331±45
(n=7)

430±62

441±48

520±61*

567±103*

TNF
(1000 ng)

257±47
(n=6)

325±17

319±37

339±27

335±27

IL-6
(1000 ng)

354±84
(n=5)

372±71

395±95

528±164

360±130

PLASMA EPINEPHRINE (pg7ml)

Time (min)
SALINE

0

30

60

90

180

200±41
(n=5)

256±43

217±41

212±33

233±36

IL-1
(1000 ng)

159±23
(n=7)

207±26

256±48

349±64*

378±59*

TNF
(1000 ng)

123±22
(n=6)

165±18

159±34

162±28

164±31

IL-6
(1000 ng)

141±17
(n=5)

197±43

166±44

176±54

142±41
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plasma catecholamines were unaffected by PVN injection of IL-6 (table 7-2 and table 7-

3).

137

DISCUSSION

Systemic administration of TNF has been shown to induce modest to marked
elevation of plasma catecholamines, depending on the doses and animal species used
(11,53,236). Intravenous treatment of IL-1 has also been demonstrated to evoke slight
activation of the sympathoadrenal system (21,202). Such activation induced by these two
cytokines can occur in the absence of hypotension (21,53), which suggests that baroreflex
mechanisms are not likely to be important in mediating cytokine effects. A variety of
experimental findings have suggested that many systemic cytokine effects are mediated
via their actions on the central nervous system (CNS), particularly the hypothalamus
(194,201). However, the specific mechanisms by which the central cytokines mediate the
observed increases in sympathetic outflow is not yet known.
In the present study we investigated the effects of centrally- administered endotoxin
and cytokines on the sympathetic outflow in order to gain some insight as to the
mechanism of sympathoadrenal activation during sepsis. The principle findings of this
study demonstrated that ICV administration of endotoxin did not cause any change in
sympathetic activity. ICV injection of IL-1 induced a modest activation of the
sympathetic nervous system where RSNA and plasma catecholamines changed basically
in a parallel manner. ICV injection of IL-6 or TNF, however, suppressed the RSNA
without significant alterations in plasma catecholamines. PVN administrations of IL- I
induced a mild elevation of plasma catecholamines without significant effects on RSNA.
PVN treatment of TNF slightly decreased RSNA slopes but did not affect plasma
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catecholmines. IL-6 injection to PVN altered neither RSNA nor plasma catecholamines.
These results suggest that IL-1 may be one of the mechanisms involved in mediating
sympathoadrenal activation during septic shock via its central actions, partially in the
PVN.

The enhanced catecholamine secretion following ventricular IL- I in the present study
is in agreement with the previous report by Rivier et al. (202). In their study similar
doses of ICV IL-1 induced comparable elevations of plasma catecholamines. The
magnitude of catecholamine increments with ICV IL-1 also resembled that induced by
systemic IL-1 treatment where higher doses of IL-1 were often used (21,202). The
augmented sympathetic outflow with IL-1 was further substantiated, in the present study,
by demonstration of an increased renal sympathetic nerve activity. Although the
magnitude of the sympathetic response, in this study and in previous study, is apparently
less compared to the sympathetic activation following systemic endotoxin (93,113), the
doses of IL-1 used may not reproduce the true local IL-1 concentration in the brain
parenchyma during endotoxicosis. The time course of ICV IL-1 induced sympathetic
activation is, however, delayed (peak at 30-90 min) compared to systemic endotoxin
evoked activation (peak at 15-30 min), even without considering the time needed for the
synthesis of IL-1 following endotoxin challenge. These differences may suggest that
either the doses of IL-1 given are not high enough to induce full stimulation of
sympathetic nervous system or IL-1 is only one of several factors responsible for the
initiation of the sympathetic activation. At least we can conclude that the
sympathoadrenal activation during the development of septic shock may be partially
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mediated by IL-1 via its central actions.
The mechanisms by which ICV IL-1 leads to the activation of the sympathoadrenal
system can not be determined in the present study, but an apparent lack of hypotension
following central IL-1 does not suggest the involvement of cardiovascular reflexes.
Several other possibilities should also be considered. First, IL-1 may directly affect the
CNS neurons which control the central sympathetic outflow. The hypothalamus would
appear to be the most likely area since it has been shown to be involved in many IL-1
induced central effects such as fever, acute phase response, CRF secretion and
suppression of food intake (66,118,194,214). Electrophysiological studies show that IL-1
can directly stimulate hypothalamic neurons to alter the firing rate (107). Furthermore,
the hypothalamus, particularly the paraventricular nucleus (PVN), is involved in central
regulation of the sympathetic nerve system (226). However, IL-1 delivery to the PVN
at concentration higher than achieved with ICV route evoked a smaller and somewhat
delayed sympathoadrenal response compared to that induced by ICV IL-1. This result
suggests that other brain areas in addition to the PVN are involved in ICV IL-1 effects.
Second, pyrogenic effects of IL-1 usually involve activation of the sympathetic nervous
system in selective organs. However, this is unlikely to be the case in present study
because IL-1 induced fever usually involves cutaneous sympathetic activation and
simultaneous renal sympathetic inhibition (204). Although temperature was not evaluated
in this study, renal sympathetic nerve activity was not decreased but increased. Third,
centrally administered IL-1 can stimulate the hypothalamus to secrete corticotropinreleasing factor (CRF) (22,206). Central CRF is known to act within the brain to
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stimulate sympathetic outflow and result in elevation of plasma catecholamines (38).
ICV administration of endotoxin has been demonstrated to induce fever production
(165) and suppression of peripheral immune systems (227). Thus, endotoxin can
somehow directly interact with the brain elements to cause functional changes. Some of
the effects can be abolished or attenuated by cyclooxygenase inhibitor or a-MSH
(165,227). Since prostaglandins have been shown to be the secondary signal of IL-1
induced fever and a-MSH has anti-IL-I effects, endotoxin effects may indeed be
mediated by brain-produced IL-1. Studies have shown that IL-1 activity is detected in
cerebral spinal fluid following central endotoxin administration (54). The failure of ICV
endotoxin injection to evoke sympathetic activation in the present study does not rule out
the possibility that brain cells can produce cytokines in vivo. Likewise, the endotoxininduced IL-1 may not be sufficient enough to stimulate central sympathetic outflow.
In contrast to IL-1, TNF (at both high and low doses) significantly suppressed the
renal sympathetic nerve activity following ICV administration. Previous studies have
shown that TNF a administered peripherally to rabbits at the dose of 10 µg/kg resulted
in a decrease in ear temperature, indicative of cutaneous sympathetic activation, and
simultaneous inhibition of renal sympathetic nerve activity at the initial phase (30 min)
which returned to control levels around 60 min post treatment (204). The parallel
changes of renal sympathetic activity following peripheral TNF in this previous study and
the central TNF in the present study suggest a possible central site of TNF action. The
much higher dose required for peripheral route as compared to the central route adds
further support to the notion that TNF effects on renal sympathetic outflow are mediated
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via its central actions. The longer durations of renal sympathetic suppression in the
present study may be attributed to high central concentration achieved. A previous study
using ICY TNF

0t

in rats also reported decreased sympathetic activity to the

interscapular brown adipose tissue (106). The absence of plasma catecholamine changes
concomitant with depression of renal sympathetic activity may be due to the net results
of non-uniform alterations of sympathetic efferents to different organs, i.e. sympathetic
impulse to some organs may be depressed while to others augmented. It should be noted,
however, that systemic TNF usually induces modest to marked elevations of plasma
catecholamines (11,53,236) whereas centrally administered TNF, in this study, does not
affect plasma catecholamine levels. This discrepancy may suggest that either the local
concentration of TNF in the effective site is not sufficiently high or systemic TNF effects
on sympathetic nervous system are not exclusively mediated via its central actions. To
expose brain parenchyma cells to a higher local TNF concentration, TNF was further
administered directly to PVN, one of the important central regulatory areas for the
sympathetic nervous system as well as the potential site of cytokine actions. TNF
injection to PYN induced a slight decrease in RSNA slopes and spikes (the latter was not
statistically significant), but did not affect plasma catecholamines. The smaller decreases
in RSNA caused by TNF injection to PYN compared to that induced by TNF injection
to ICY may indicate that PYN is not likely the only site where TNF acts to induce the
sympathetic suppression.
One possible mechanism of central TNF action may be a direct effect on the
electrophysiology of sympathetic regulatory neurons. TNF has been shown to decrease
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the transmembrane potential of skeletal muscle (237) and influence the firing rate of the
neurons in the CNS (180,194). For example, electrophoretically applied recombinant
human-TNF (rh-TNF) suppressed the activity of glucose-sensitive neurons in the rat
lateral hypothalamic area (194) and increased neuronal activity of glucoreceptor neurons
in the rat ventromedial hypothalamic nucleus (180). The ionic mechanism of the
inhibitory effect of TNF has been proposed to be the inactivation of resting sodium
conductance (209). A decrease in potassium conductance may underline the excitatory
effects ofTNF (208). We speculate that ventricularly applied TNF may somehow directly
or indirectly either stimulate the inhibitory neurons or suppress the excitatory neurons
in the sympathetic control circuit and results in decreases of the renal sympathetic
activity.
Similar to TNF, ICV injection of IL-6, at a high dose, also induced suppression of
the renal sympathetic activity. The mechanisms of this finding are not known, but
apparently ICV IL-6 effects on the sympathetic nervous system are not mediated in PVN
since IL-6 injection to PVN affected neither RSNA nor plasma catecholamines. Previous
studies have shown that IL-6 has various effects on the central nervous system such as
fever induction and stimulation of hypothalamic-pituitary-adrenal axis (100,170). IL-6
induced ACTH release in rats could be abolished by pretreatment with anti-CRF
antibodies, suggesting that IL-6 effects was mediated via CRF.
As discussed above, the alterations of sympathetic nerve activity associated with
PVN injection of either IL-1 or TNF were somewhat delayed and less in magnitude
compared to those induced by ICV injection of a similar dose of these cytokines. An
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alternative explaination for this observation is that cytokines injected into the PVN may
migrate with time to adjacent areas such as cerebral ventricles and thereby cause
subsequent changes in sympathetic nerve activity.
Whether cytokines can cross the blood brain barrier and gain direct access to the
brain parencymal cells is controversial. Generally, it is believed that molecules as big as
endotoxin or cytokines are unlikely to cross the blood brain barrier. Studies with
intravenous administration of radiolabled endotoxin and IL-1 have shown inconsistent
results in terms of detection of radioactivity in the brain (12,20,67, 109). Several authors
have proposed that cytokines may gain access to the brain, particularly the hypothalamus,
via circumventricular organs such as organum vasculosum laminae terminalis (OVLT),
where there is no blood brain barrier (26,116,222). Furthermore, all three cytokines can
be produced in vivo and in vitro by brain cells such as astrocytes, microglial cells or even
neurons in response to endotoxin challenge or various other pathological conditions
(82,95,135,182,200). Recently, Breder et al. reported that IL-1 immunoreactive fibers
were found innervating the key endocrine and autonomic cell groups and were distributed
in a manner as to suggest that it functions as a neuromodulator or neurotransmitter
(34,136). Collectively, the substrates for potential interaction of brain cells with
circulating, even locally produced cytokine, are possibly present.

It is not known how much the ventricularly applied cytokines might mimic the true
exposure of the brain cells to circulating, or even locally produced, cytokines during
septic states. Considering the normal volume of cerebral spinal fluid (300 µl) and rate
of secretion (2.2+0.3 µI/min) in the rat, the concentrations of the cytokines at 30, 60,
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90 and 180 min after ICV injection would be 81, 66, 53, and 28% of the initial amount.

It is also difficult to estimate how much the timely-diluted cytokines diffuse from CSF
across the ependymal epithelia and pial surfaces into the brain parenchyma. From
previous reports on radiolabled peptides and chemicals, after ICV administration, their
concentrations within the brain target region surrounding the ventricular cavities (e.g. the
hypothalamus) and subarachinoid space may be less than 2 % of the initial amount. This
represents less than 20 ng after a dose of 1 µ.g/rat of cytokines without taking enzymatic
peptide degradation and turnover of CSF into account. Although injection of 1000 ng of
cytokines into the brain parenchyma seems unphysiological, considering the potential
local production of cytokines in the brain, an even greater amount of the cytokines than
that measured in the circulation, i.e approximately 10-s to 10-10 g/ml, may be available
to neuronal target sites.
In summary, the present study suggests that the sympathoadrenal activation during
septic challenge may be partially mediated by IL-1 via its central actions. Furthermore,
paraventricular nucleus of the hypothalamus appears to be one of the sites mediating
cytokine induced sympathetic response.

CHAPTER VIII

SUMMARY AND CONCLUSIONS

Sympathoadrenal activation is one of the most dramatic pathophysiological changes
which occur during septic/endotoxic shock. Such increased sympathetic nerve activity has
been linked to both beneficial and detrimental effects on the development of the shock
process. The present dissertation study examined potential mechanisms involved in
mediating sympathoadrenal activation during experimental endotoxicosis.
The first project evaluated the overall contributions of central versus peripheral
mechanisms to the sympathoadrenal activation in endotoxic animals. Specifically, plasma
catecholamine responses to endotoxin challenge were compared between rats with and
without central regulatory mechanisms, i.e. conscious and pithed rats, respectively.
Plasma EPI following endotoxin was further assessed in adrenal denervated conscious and
pithed rats to illustrate the neurogenic or non-neurogenic characteristics of peripheral
modulation of adrenal EPI release.
Summary of results from the first project:
1. Endotoxin induced a marked elevation in plasma NE in conscious rats, but elevations
were not seen in pithed rats.
2. Endotoxin also induced a profound increase in plasma EPI in conscious rats, but
145
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increases were much less and delayed in pithed rats.
3. Plasma EPI elevation following endotoxin was delayed in conscious adrenal denervated
rats compared to adrenal sham-operated rats. This elevation was approximately one third
of the maximum response observed in sham controls.
4. The delayed plasma BPI elevation was also seen in pithed adrenal denervated rats,
which was not different from that in pithed adrenal intact rats.
Conclusions drawn from the first project:
1. The increased plasma NE in response to endotoxin challenge is centrally mediated.

2. The increased plasma BPI following endotoxin involves both central and peripheral
mechanisms with the former being dominant.
3. Peripheral modulation of adrenal BPI release is most likely non-neurogenic, which
contributes to the prolonged plasma BPI response during endotoxicosis.

The second project examined the role of afferent neural input from arterial
baroreceptors in mediating the sympathoadrenal activation during endotoxicosis.
Specifically, plasma catecholamines and/or RSNA were assessed in anesthetized rats with
acute SAD and conscious rats with chronic SAD.
Summary of results from the second project:
1. Bndotoxin induced a similar, if not higher, elevation in plasma catecholamines in
anesthetized rats with acute SAD compared to baroreceptor intact sham rats.
2. Bndotoxin induced rapid and sustained increases in both plasma catecholamines and
RSNA in conscious rats with chronic SAD. The early increments in plasma
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catecholamines and RSNA were more profound in SAD rats than sham animals.
3. Plasma catecholamines were significantly increased by hydralazine-induced
hypotension in sham rats, but not in SAD rats. This elevation was far less than that
induced by endotoxin.
Conclusions drawn from the second project:
1. Afferent neural input from arterial baroreceptors is not essential in mediating
sympathoadrenal activation during endotoxicosis, and non-baroreflexogenic mechanisms
are involved in stimulating such activation.
2. The elimination of feedback buffering mechanisms with SAD may account for the
augmented sympathetic response seen in SAD animals.

The third project tested the hypothesis that cytokines may be involved in mediating
the sympathoadrenal activation during endotoxicosis, via their actions on the central
nervous system. Specifically, IL-1, TNF, or IL-6 in addition to endotoxin was
administered into the lateral ventricle of conscious rats, and plasma catecholamines and
renal sympathetic nerve activities were assessed. To examine whether the PVN is the
anatomical site of cytokine actions, each of the cytokines was delivered into the region
of the PVN, and plasma catecholamines and RSNA were determined following the PVN
injection.
Summary of results from the third project:
1. ICV injection of endotoxin did not significantly change plasma catr..cholamines or
RSNA.
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2. ICV injection of IL-1 induced modest increases in both plasma catecholamines and
RSNA. PVN injection of IL-1 also induced a mild elevation of plasma catecholamines
without significant effects on RSNA.
3. ICV injection of TNF resulted in a slight attenuation of RSNA without significant
effects on plasma catecholamines. RSNA was also slightly decreased following PVN
injection of TNF without significant alteration in plasma catecholamines.
4. ICV injection of IL-6 caused decreases in RSNA and no changes m plasma
catecholamines. PVN injection of IL-6 altered neither RSNA nor plasma catecholamines.
Conclusions drawn from the third project:
1. The sympathoadrenal activation during developing septic/endotoxic shock may be

partially mediated by IL-1 via its central actions while the direct effects of cerebral
ventricular TNF and IL-6 suppress renal sympathetic activity.
2. The alterations of sympathoadrenal activity associated with ventricular IL-1 and TNF
may be mediated, in part, by their actions on PVN. The sympathetic suppression with
ventricular IL-6 is not likely mediated by actions on PVN.

The sympathoadrenal activation in response to septic/endotoxic challenge involves
very complicated processes in peripheral sensory structures, afferent nerves, central
neuronal networks, efferent sympathetic nerves, and the adrenal medulla. Endotoxin,
endotoxin-elaborated host factors and various pathophysiological alterations associated
with septic shock may interact with those neuronal elements at different levels and result
in enhanced activity of the sympathoadrenal system.
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As can be integrated from the present study as well as previous works, a schematic
representation of sympathoadrenal regulation during septic/endotoxic shock is presented
in Fig. 8-1. Endotoxin, released from the invading gram-negative bacterial wall,
stimulates macrophages as well as a variety of other cell populations to release cytokines
and numerous other host factors such as eicosanoids, bradykinin and histamine. These
factors, particularly cytokines, are important mediators of the hemodynamic, metabolic,
and neuroendocrine alterations associated with septic/endotoxic shock.
In terms of neuronal reflex mechanisms, decreased blood pressure and venous return
with ultimate volume depletion during septic shock may deactivate both arterial
baroreceptors and cardiopulmonary volume receptors, and reflexly result in increment
of central sympathetic outflow. Blood borne factors such as epithelial derived factors,
PGl2 , opiates, and neurotensin may also modulate baroreflexes at different levels of the
baroreflex arc including baroreceptors and NTS (48,49,228,256), which may also lead
to augmented sympathetic activity. However, marked sympathoadrenal activation could
occur in septic patients and animals without hypotension or hypovolemia (89,115).
Alternatively, such activation persists after recovery of hypotension with volume infusion
(185). Furthermore, profound sympathetic activation is observed in baroreceptor
denervated endotoxic animals in the present study (255). These results suggest that baroand volume- receptor reflexes are not likely to be essential for turning on and
maintaining the sympathoadrenal activation during septic shock, despite their participation
in such activation. It is noteworthy that stimulations of mechano- or chemo-sensitive
nerve endings in abdominal visceral organs also evoke cardiovascular reflexes, which are
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frequently excitatory (144,145). Such reflexes can be stimulated by passive distension,
local temperature changes, altering vessel pressure and intraarterial injection or topical
application of certain chemicals such as bradykinin, histamine and capsaicin
(144-146,181). Although this reflex mechanism has implications in the sympathetic
response during septic shock, the importance has not been studied.
Metabolic alterations associated with septic shock may also be involved in
sympathetic response. Changes in blood pH as a result of hyperlacticemia and acidosis
may stimulate peripheral and central chemoreceptors and result in enhanced sympathetic
outflow. A previous study showed that the plasma epinephrine response to hemorrhagic
shock was blunted after prevention of acidosis by intravenous administration of sodium
bicarbonate (58). Insulin-induced hypoglycemia also leads to elevations of plasma
catecholamines presumably through both neurogenic and non-neurogenic mechanisms
(120). The neurogenic mechanism likely involves stimulations of gluco-sensitive receptors
in the hypothalamus and spinal cord (175). Since these metabolic alterations are usually
delayed processes, they do not appear to account for the rapid onset of sympathoadrenal
activation during developing septic shock.
Recently, increasing attention has been drawn to the cytokine-mediated modulation
of neuroendocrine systems, which is a plausible mechanism for sympathoadrenal
activation during septic shock. Although cytokines appear unable to cross the blood brain
barrier in significant quantities, r~ent studies suggest that cytokines may enter the brain
at sites where blood brain barrier is absent such as OVLT (26,116,222). A further
possibility is that circulating cytokines can somehow interact with the brain and stimulate
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its own cytokine productions (34,203). Systemically and centrally administered cytokines,
particularly IL-1, have been shown to exert many actions in the brain including the
stimulation of the sympathoadrenal system (53,202,203). This sympathetic activation can
be evoked by IL-1 via its direct effects on sympathetic regulatory neurons or via some
secondary neural or humoral factors. For example, IL-1 is a potent endogenous pyrogen
which can induce fever, and the associated thermogenesis is usually accompanied by
selective activation of efferent sympathetics and adrenergic mediated vasoconstriction
(91). IL-1 also stimulates the hypothalamic-pituitary-adrenal axis primarily via releasing
CRF from the hypothalamus, and CRF has long been recognized to enhance central
sympathetic outflow (38). PVN seems to be one of IL-1 action sites in evoking
sympathetic activation.
Non-neurogenic modulation of adrenal catecholamine release may involve direct
actions of hypoxia, endotoxin-elaborated endogenous mediators or endotoxin itself on the
adrenal medulla (166,225). Numerous endogenous substances such as histamine,
bradykinin, angiotensin II, and vasoactive intestinal polypeptide have been shown to
stimulate adrenal gland or chromaffin cells to secret catecholamines (130,142,153,177).
Further studies are needed to determine, in a more systematic and comprehensive
manner, the role of cytokine mediated modulation of the sympathoadrenal response
during developing septic shock and the mechanisms underlying this modulation.
Hypophysectomized animals could be used to determine whether the hypothalamus is the
primary center of cytokine modulation. Since the OVLT has been proposed to be the
entry or action site of circulating cytokines to the hypothalamus to mediate their
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pyrogenic effects and hypothalamic-pituitary-adrenal stimulation, experiments with OVLT
lesions or direct injection of cytokines to OVLT may help understanding the OVLT
involvement in sympathetic response to endotoxin and cytokines. Electrophoretically
sampling in a confined hypothalamic area may allow the evaluation of the quantity and
time course of local cytokine production during endotoxicosis as well as its correlation
with sympathetic activation. Assessment of sympathetic activity in septic animals after
application of specific cytokine antibodies to the brain areas suspected to be the cytokine
production and action sites would provide additional valuable information on central
cytokine involvements in sympathetic response during developing septic shock.
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